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Family health history (FHH) is an independent risk factor for predicting an 
individual's chance of developing selected chronic diseases. Though various FHH tools 
have been developed, many research questions remain to be addressed. Before FHH can 
be used as an effective risk assessment tool in public health screenings or population-
based research, it is important to understand the quality of collected data and evaluate 
risk prediction models. No literature has been identified whereby risks are predicted by 
applying machine learning solely on FHH. This dissertation addressed several questions. 
First, using mixed methods, we defined 50 requirements for documenting FHH for a 
population-based study. Second, we examined the accuracy of self- and proxy-reported 
FHH data in the Health Family Tree database, by comparing the disease and risk factor 
rates generated from this database with rates recorded in a cancer registry and standard 
public health surveys. The rates generated from the Health Family Tree were statistically 
lower than those from public sources (exceptions: stroke rates were the same, exercise 
rates were higher). Third, we validated the Health Family Tree risk predictive algorithm. 
The very high risk (≥2) predicted the risk of all concerned diseases for adult population 
(20 ~ 99 years of age), and the predictability remained when using disease rates from 
public sources as the reference in the relative risk model. The referent population used to 
establish the expected rate of disease impacted risk classification: the lower expected 
disease rates generated by the Health Family Tree, in comparison to the rates from public 
iv 
sources, caused more persons to be classified at high risk. Finally, we constructed and 
evaluated new predictive models using three machine learning classifiers (logistic 
regression, Bayesian networks, and support vector machine). A limited set of information 
about first-degree relatives was used to predict future disease. In summary, combining 
FHH with valid risk algorithms provide a low cost tool for identifying persons at risk for 
common diseases. These findings may be especially useful when developing strategies to 
screen populations for common diseases and identifying those at highest risk for public 
health interventions or population-based research. 
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Chronic diseases such as heart disease, stroke, cancer, and diabetes are common, 
expensive, but preventable health problems in the United States.
1
 A positive family health 
history is often considered an independent risk factor for these diseases.
2
 This dissertation 
focuses on using family health history information and personal lifestyle risk factors to 
assess a healthy individual's risk of developing selected chronic diseases. Preventing the 
onset of chronic disease is an important strategy for population health.  
The following hypotheses were tested by the research described in this 
dissertation: 1) The requirements for documenting family health history for population-
based studies and public health will differ from the published requirements for integrating 
family health history in an electronic health record system; 2) The disease rates generated 
from self-reported and proxy-reported family history data are similar to the rates recorded 
in public databases; 3) A current risk algorithm can predict a healthy individual's risk for 
developing certain chronic diseases, based on self- and proxy- reported family health 
history information; and  4) A new prediction model based on machine learning can 
predict a healthy individual's risk for developing chronic diseases, using diabetes as an 
example. 
Each chapter of this dissertation addresses a different component of the research. 
Chapter 2 provides background information about chronic diseases, family health history 
2 
 
and the rationale for conducting this research. Chapter 3 provides a description of 
requirements for documenting family health history for longitudinal population-based 
studies and public health, and an evaluation of a national tool for meeting the 
requirements. Chapter 4 provides an examination of the accuracy of family health history 
data by comparing disease rates generated from self- and proxy-reported data with rates 
generated from a cancer registry and public health standardized surveys. Chapter 5 
provides a validation of the current risk algorithm for predicting a healthy individual's 
risk for developing certain chronic diseases by using the individual's family health 
history. Chapter 6 includes a description and evaluation of new risk prediction models for 
diabetes using three machine learning methods. Finally, Chapter 7 includes a discussion 
of the implications and potential future work associated with the research presented in 
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Chronic Diseases in the United States 
 
Chronic diseases are ongoing, often incurable illnesses or conditions, such as 
heart disease, cancer, and diabetes. Approximately 133 million Americans, 45% of the 
population, are affected by at least one chronic disease.
1
 By 2020, the number is 
projected to grow to 157 million, with 81 million persons having multiple conditions.
2
 
Among persons age 65 and older, half (51%) have  hypertension and approximately a 
third have arthritis (37%) or  heart disease (29% ).
3
  These three conditions are the most 
common chronic diseases among persons over 65 years of age. 
3
  Chronic diseases are the 
leading cause of death and disability in the United States. Each year, 7 out of 10 deaths in 
the United States are due to chronic diseases. Heart disease, cancer, and stroke are 
responsible for more than 50% of all deaths.
4
 About 25% of people with chronic diseases 
have some type of activity limitations.
3
 Chronic diseases also account for the majority of 
health spending in the United States: more than 75% of the health care costs, about $2 
trillion, are due to chronic conditions.
5
 The most expensive chronic diseases, heart 
disease and stroke, cost Americans $432 billion per year.
6
  
Many chronic diseases are preventable if individuals address the myriad of risk 
factors that contribute to the onset of disease. For example, tobacco use in the United 
States since the 1950s has declined greatly from 57% to 23% among men, and from 34% 
5 
 
to 18% among women.
7
 This decrease happened after the 1964 report of the surgeon 
general, which linked smoking and lung cancer.
8
 A report by the CDC also showed that 
one year after quitting smoking, excess risk for heart disease can drop 50%
9
; exercise at 
moderate intensity and lowered intake of fat and calories can reduce the risk for diabetes 
by 58%.
9
 The World Health Organization has estimated that 80% of heart disease, stroke, 
and type 2 diabetes and 40% of cancers would be prevented if the following three risk 
factors for chronic diseases were eliminated: physical inactivity, poor diet, and 
smoking.
10
 The goal of public health is to prevent chronic diseases through primary 
prevention (i.e., health promotion efforts that encourages healthy living), secondary 
prevention  (i.e., screening efforts for early detection among at-risk populations), and 
tertiary prevention (i.e., management of existing diseases).
9
 Given that half of all chronic 
disease is caused by unhealthy behaviors, there is a need to develop tools to identify those  









There are four major determinants that affect a person’s health: biology, 
environment (including physical and social), lifestyle, and healthcare.
11
 The description 
of genetic relationships and medical history of a family, known as family health history 
(FHH), reflects all of the determinants contextualized within the family, such as genetic 
predispositions, shared environmental factors, common lifestyle factors, and shared 
healthcare.
12
 Among medical practitioners, FHH is traditionally considered one of the 
major components for a complete medical history in the official medical record. FHH has 





 FHH has also been used by public health professionals to identify high risk 
populations and then, based on the assessed level of risk, to apply screening strategies for 
chronic diseases.
12,15
 For example, positive FHH of diabetes,
16-20
 coronary heart disease 




  or various cancers
30-34
 are all 
considered risk factors for these diseases. In the more recent era of genomic and 
personalized medicine, FHH still retains its importance. Being a noninvasive, low-cost, 
and proven tool, FHH is given new meaning and power to interpret the complex 
interactions between gene and environment that cause different levels of health and 
disease.
35
 Though the cost of sequencing a person's genome has dropped significantly, 
the interpretation of the genetics and the interaction of the genetic and environmental 
factors are far from being completely understood and may still be best represented by the 
FHH. In addition, FHH may be used to determine the likelihood of whether or not genetic 
variations will be pathologic for a specific individual. Furthermore, FHH also reflects the 
shared behavioral factors such as diet and exercise within the family. Thus, FHH is used 
as an important tool in different health related areas: in clinical medicine, FHH is used to 
diagnose and manage affected patients
7
; in public health, FHH is used to stratify a 
healthy population to identify high risk subpopulations and to prevent chronic diseases 
through health education and/or health screening
15,36
; and finally, in population-based 
research, FHH is used to stratify risk within the study population for descriptive analysis 
or to select cases and controls for future genetic and epidemiologic analysis. This 
dissertation seeks to apply FHH to risk assessment for longitudinal population-based 
research and public health screening strategies.  
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Family Health History Tools 
To better use FHH for risk assessment either in clinical or public health settings, 
many tools have been developed. Traditional paper-based tools such as the American 
Medical Association's Prenatal Genetic Screening Questionnaire,
37
 Pediatric Genetic 
Screening Questionnaire,
38
 and Adult Family History Form
39
 are used to collect 
information for screening, diagnosis, and treatment. The last decade has seen rapid 
development of informatics tools, including computerized and web-based tools. For 
example, in 2004, the Surgeon General initiated a national public health campaign
19
 that 
released a web-based tool, My Family Health Portrait,
40
 for the public to collect, save, 
and share the family’s medical history of multiple diseases and conditions with their 
healthcare providers and family members. This tool is publicly available and uses 
standard vocabulary (including LOINC® and SNOMED-CT) and the HL7 family history 
data model to allow interoperability with electronic health records.
41
  
Other than My Family Health Portrait, various universities, health organizations, 
and research institutes have also developed tools to meet their needs for collecting, 
interpreting, and applying FHH. Family Healthware
42
 is a web-based research tool 
developed by the Centers for Disease Control and Prevention to assess a person's familial 
risk for six chronic diseases, including diabetes, CHD, stroke, and colon, breast, and 
ovarian cancer. Alternatively, MyGenerations
43
 collects family history on cancers and 
provides risk assessment. Your Disease Risk
44
 assesses the risks for diabetes, heart 
diseases, stroke, osteoporosis, and cancer using family history and lifestyle risk factors 
information. Hughes RiskApps
45
 allows family history and other risk data to be entered 
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and calculates risks for breast and ovarian cancer. Similar tools for different cancer or 










Utah's tool: Health Family Tree 
 
Health Family Tree is an additional tool that uses FHH to predict risk. The Health 
Family Tree program was developed by researchers in Utah and Texas in the early 
1980s.
49
 The tool included a paper-based questionnaire and a computer-based database 
and algorithm. The questionnaire was distributed to high school students in Utah through 
their required Health Education class. From 1983 to 2001, 57,238 students in 55 high 
schools collected their family history by documenting information about common 
diseases and general lifestyle risk factors about their family members.
50
 Their family 
members included the student’s siblings, parents, aunts, and uncles and grandparents. The 
common diseases included: diabetes, MI, CHD, stroke, high blood pressure, high blood 
cholesterol, breast cancer, lung cancer, and colon cancer. The lifestyle risk factors 
assessed included: smoking, drinking, being overweight/obese, and exercise. The 
information was collected with consent by each student as assigned homework, with help 
from their parents, on a 36 x 23 inch folding paper that was designed to fit on a kitchen 
table. The collected information was transcribed and stored in a database, and an 
algorithm was developed to automatically predict the risk for the above diseases.
51
 The 
algorithm predicted risk based on comparing the observed number of disease events to 
the expected number of disease events within the family. The expected number of events 
was calculated by multiplying the age- and sex-specific person-years for each person in 





 The large volume of persons represented in the data and the systematic 
collection of information from a large number of high school students throughout the 
state led to the assumption that the expected number of events could be derived from the 
database itself.  
Besides the database, the Health Family Tree program also developed an 
algorithm to calculate the risks of developing the above diseases. This risk algorithm was 
validated in 1986 for predicting heart diseases.
51
 The researchers found that the definition 
of elevated risk from the Health Family Tree algorithm successfully predicted unaffected 
family member’s risk of developing future CHD. In addition, preliminary analysis of the 
tools ability to predict MI and diabetes was reported in 2009.
52
 The Health Family Tree 
tool has been used by the Utah Department of Health for the purpose of screening 
populations in the community since it was developed. A web-based version of the Health 
Family Tree (http://healthfamilytree.utah.edu/) was developed in 2005 and could  
continue to serve similar purposes on a larger scale. 
 
 
Requirements for Documenting Family Health History 
 
Before expanding data collection about FHH using any tools, it is essential to 
understand the requirements for collecting FHH. Various tools collect different family 
history information based on their own needs; thus, the collected data vary greatly in 
terms of required data elements and the degree of relatives that are included. In 2008, the 
American Health Information Community (AHIC), a federal group formed to advise the 
Secretary of the Department of Health Human Services on methods of increasing 
electronic health record adoption in healthcare facilities, published the data requirements 





 This core data set may or may not be adequate to develop or select 
informatics tools for documenting FHH for longitudinal population-based research or 
screening. Furthermore, in addition to the data requirements, other functional and 
nonfunctional requirements must be defined for documenting FHH. No current literature 
addresses these other requirements, such as functional requirements for using and 
maintaining the collected FHH data or the usability requirements for collecting FHH. 
When developing or adopting any computer-based systems, it is critical to incorporate 
usability into the process.
54
 One study showed that the ultimate acceptance or rejection of 
a healthcare information system is largely dependent on the system’s usability.55 The 
usability issue is even more important for developing or adopting tools to collect family 
history information from the general public, because the system must accommodate 
various languages, levels of education, and computer skills. A well-designed, user 
friendly computerized tool may reduce the burden and save the time needed for entering 
FHH, thereby potentially increasing the completeness of the information. A tool with 
good usability may also reduce human errors during data input and hence improve the  
quality of the information collected.  
 
 
Accuracy of Family Health History 
 
Although the literature has shown that FHH information can be used for risk 
assessment, the quality of data collected needs to be examined. Using the Health Family 
Tree as an example, the information about the students and their siblings and parents was 
self-reported while information about the student’s aunts, uncles, and grandparents was 
classified as proxy-reported. These methods, both self-report and proxy-report, have been 
widely used to collect FHH data. To collect an individual’s family history, informants 
11 
 
(students and their parents in this case) need to not only report on their own medical 
history and risk factors (self-report) but also report on the medical history and risk factors 
of their first, second, or even third degree relatives (proxy-report). According to a 
systematic review by the National Institute of Health in 2009, the accuracy of FHH varies 
based on the disease being studied.
56
 In general, correct reporting of the absence of 
disease in relatives was better than correct reporting of the existence of disease.
56
 The 
results from multiple studies showed that the specificities of reporting family history of 
cancer were high, ranging from 0.91 to 1.00. In contrast, the sensitivities reported in these 
studies varied by the type of cancer: breast, 0.72 to 0.95; colon, 0.33 to 0.90; ovarian, 
0.38 to 0.42; and prostate, 0.47 to 0.79.
56
 Similar patterns were observed for reporting 
family history of other diseases such as diabetes, hypertension, and cardiovascular 
disease: the specificities were high, ranging from 0.76 to 0.98, and the sensitivities varied 
greatly from 0.18 to 0.89.
56
 No clear association was observed between accuracy and 
informant age, sex, or educational level. In 1986, a data accuracy study was also 
performed to assess the quality of the information reported by the student and their 
parents for their relatives in the Health Family Tree program. A subset of the families 
was selected and the family members were contacted by mailing a questionnaire with 
additional questions, phone calling, or personal interviews to confirm the reported disease 




The accuracy studies described above used similar methods to verify the relatives’ 
actual disease status. The methods require locating each relative’s medical records, 
records in disease or death registries,  or contacting the relative directly. While these 
12 
 
methods are advantageous because they directly capture the history of the person, there 
are several disadvantages. For example, the methods require finding the existing records 
or contacting multiple relatives, which makes the accuracy evaluation very resource- and 
time-consuming. Alternatively, if the rates of disease and risk factors generated from one 
data source are similar to the rates available from publicly available sources, the accuracy 
of this data source may be validated on the population level and fewer resources will be 
used. These strategies address the accuracy of the counts of events that comprise the 
numerator in the rate calculation.  
When assessing the Health Family Tree risk assessment algorithm, it is also 
important to evaluate the accuracy of the expected rates being used to define the expected 
occurrence of disease.  The Health Family Tree risk assessment algorithm relies on the 
disease rates generated from the database itself. There are two major reasons to describe 
the disease rates generated by the Health Family Tree and compare the rates with general 
population disease rates: 1) to test the assumption that it is valid to generate expected 
rates using the Health Family Tree database, and 2) to generalize the risk algorithm used 
in this program and possibly implement the algorithm in a standalone decision support 
system for risk prediction and disease prevention. Other decision systems could use the 
publicly available data in the risk predictive algorithm and assess the risks for medical or 
public health decision support without the need of a database that contains a large amount 
of records. Currently, the relationship between the self- and proxy- reported information 
in the Health Family Tree and information from public sources is unknown. 
13 
 
New Predictive Model Using Family Health History 
The algorithm used in the Health Family Tree program is based on classical 
statistical methods and was implemented in 1983. Since 1983, new methods have been 
developed to discover knowledge in large databases. For example, machine learning 
methods use a discovery process to describe structural patterns. These patterns may be 
used to predict outcomes from any similar data. While both statistical and machine 
learning methods have evolved in parallel, there are important differences. Statistical 
methods are more concerned with testing hypotheses, whereas machine learning methods 
are more concerned with formulating the process of generalization.
57
 
Recently, data mining and machine learning methods have been used to analyze 
healthcare data, which is known to be complex and voluminous. For example, these 
methods have been applied to control hospital infections, to rank hospitals, and to 
identify high risk patients.
58,59
 Studies applying machine learning methods to multiple 
risk factors including FHH to predict the risks of developing coronary heart events and 
diabetes showed promising results.
60-63
 No literature has been identified whereby risks are 
predicted by applying machine learning solely on FHH information. 
The Health Family Tree program created a rich database that contains more than 
one million individuals’ self- and proxy- reported demographic, family relationship, 
medical history, and lifestyle risk factor information. Machine learning may help to 
develop effective predictive models for classifying high risk from low risk individuals in 
order to implement screening and population-based interventions. Compared with 
statistical models based on relative risk, the machine learning methods may have 
practical benefits for implementation. The Health Family Tree statistical algorithm 
14 
 
requires a reference population to generate the expected incidence rates. Very limited 
information about incidence rates is available for most chronic diseases. Cancer incidence 
rates are the only exception due to nationally instituted cancer registries. Machine 
learning techniques build predictive models by training on the features collected by the 
Health Family Tree tool. Ideally, these trained and validated models can be applied to  
predict disease risks in any tool that collects the required set of features. 
 
 
Filling a Knowledge Gap 
 
“Documentation of family medical history” is one of the “Meaningful Use” 
objectives defined by the US Health and Human Services.
64 
Even so, family health 
history is an important, yet underused tool in both clinical and public health settings and 
population-based studies. Possible barriers to this effort include lack of awareness of the 
importance of FHH, lack of time, lack of accurate, detailed information, and lack of 
validated risk assessment,
13-15
 and possibly poor tool support partly due to loosely 
defined requirements. Currently, there is no literature that defines requirements beyond 
data requirements, and there is no consensus on data and function requirements; 
therefore, though multiple tools exist, it is unknown how the tools can be used for 
longitudinal population-based research and public health screening. Literature has 
reported on the accuracy of self- and proxy-reported family history, but the results of 
those studies vary greatly, indicating that more research is needed. The Health Family 
Tree program was developed and has been used in the community as a screening tool for 
over 20 years, but has only been validated for heart diseases. An online version of this 
tool is developed and could be implemented in a larger community. Validating the risk 
algorithm for more diseases and health conditions may increase acceptance of the tool as 
15 
 
a population screening tool. Finally, recently developed machine learning techniques 
have not been applied in predictive models that use only FHH. How the new models built 
by machine learning techniques compare with traditionally developed predictive models 
still remains unknown. This dissertation addresses the gaps by: 1) defining the 
requirements for a tool to document FHH for longitudinal population-based studies, and 
evaluating if a current national tool meets these requirements; 2) examining the accuracy 
of self- and proxy-reported data by comparing disease rates generated from the Health 
Family Tree database with rates from public data sources; 3) validating whether the risk 
score derived from the Health Family Tree algorithm can predict an individual’s future 
risk for multiple diseases or conditions (diabetes, MI, CHD, stroke, high blood pressure, 
high blood cholesterol, breast cancer, lung cancer, and colon cancer); and 4) building and 
evaluating a diabetes predictive model through machine learning that uses only FHH and 
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Family health history (FHH) is the description of the genetic relationships and 
medical history of a family.
1
 Since families tend to live close to each other and share 
many lifestyle choices, such as diet and physical activity habits, FHH reflects the shared 
genetic susceptibility, environmental factors, and common behaviors among family 
members.
2
 These factors interact with each other and are related to health status, so FHH 
can be used as a useful proxy for factors that contribute to disease. A positive FHH for 
cancer, diabetes, or heart diseases is considered a risk factor for these diseases.
3-7
 Thus, 
FHH can be used to target prevention strategies towards individuals and populations at 
greater risk of certain diseases.
8
  
FHH is useful in longitudinal population-based research. The National Children’s 
Study (NCS) is a good example of a longitudinal study that examines the effects of 
natural or man-made environmental, biological, genetic, and psychosocial factors on the 
health and development of 100,000 children (from before birth until 21 years of age 
across the United States.
9
 The goal of the NCS was to improve the health of children in 
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future generations by identifying the genetic and environmental contributors to disease. 
Understanding FHH may be particularly valuable for some of the NCS priority health 
conditions. FHH can be used as a proxy for factors that mediate exposure-disease 
relationships to a) stratify risk within the study population during descriptive analysis, 
and b) select cases and controls for future genetic analysis. 
The collection of FHH has been enabled through the use of informatics methods 
and tools. In 2004, the Surgeon General initiated a national public health campaign
10
 and 
released a web-based tool, My Family Health Portrait,
11
 for the public to collect, save, 
and share their family history about multiple diseases and conditions with their healthcare 
providers and family members.
12
 The tool is publicly available and uses standard 
vocabulary (including LOINC®, SNOMED-CT, and HL7 Vocabulary) and the HL7 
family history data model to allow interoperability with electronic health records.
13
 My 
Family Health Portrait may be useful for population-based longitudinal studies, but its 
adequacy has yet to be evaluated. 
Currently, the collection of family health history information in the NCS is 
limited. Before expanding data collection about family health history within the NCS, it 
is important to understand the requirements for collecting family health history for 
longitudinal studies. In 2008, the American Health Information Community (AHIC) 
published data requirements (i.e., core data set) for representing FHH in an Electronic 
Health Record and Personal Health Record.
14
 This core data set may or may not 
adequately address the data needs for a longitudinal study such as the NCS. Furthermore, 
the literature does not provide sufficient detail to define functional and nonfunctional 
requirements needed for a tool that documents FHH for longitudinal studies. Finally, 
23 
 
before adapting an existing tool for a population-based study to use, it is important to 
analyze the usability of the tool for use by participants in a study.  
Therefore, the objectives of this research were to: 1) develop requirements for 
documenting FHH for a longitudinal population-based study and determine whether the 
requirements differ from the published requirements for integrating FHH into an 
electronic health record; and 2) evaluate whether the publicly available tool, My Family  







The requirement analysis involved the development of new requirements and a 
comparison with published requirements for documenting FHH in an electronic health 
record. A variety of methods were used to explore the breadth and depth of requirements 
needed for the NCS. First, the technical requirements were defined through conversations 
with one of the NCS study directors and evaluating current standards related to 
representing family history.
15-17
 Second, the data requirements were defined and 
confirmed using a variety of methods:  
a) we reviewed the 2008 AHIC publication14 and the design document used to 
develop a FHH tool for Intermountain Healthcare;  
b) we used two existing tools and identified the required data elements to collect a 
FHH and use the information for risk assessment.
18
 The two tools were: My 
Family Health Portrait,
11
 the publicly-available web-based tool developed by 
the US Surgeon General’s Office, and the Health Family Tree,19,20 a paper and 
web-based tool developed by the University of Utah; and  
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c) we interviewed five domain experts to understand the clinical and patient-
focused operational definition of clinical terms and to determine the minimum 
degree of relatives required for data collection. The five domain experts 
included: a pediatrician, and experts in preterm birth, obesity, asthma, and 
autism.  
Third, the functional requirements were defined by reviewing the two tools listed above 
and the Intermountain Healthcare design document and considering requirements that 
emerged from the other methods. Fourth, the initial usability and security requirements 
were defined by considering a) usability standards,
21,22
 b) usability issues that were 
brought up during interviews with clinicians, and c) usability issues identified during the 
evaluation of My Family Health Portrait. All the feedback from the usability evaluations 
were analyzed and iteratively incorporated into the usability requirements document. 
Finally, the ethical requirements were defined by examining the literature.
23,24
  
The supersets of requirements we developed were classified into their logical 
groupings. For each requirement, we provided justification and assessed the relevance of 
the requirement from three perspectives: 1) an NCS study field manager who needs to 
collect and manage the information, 2) an NCS study participant who needs to collect and 
update the information periodically during at least 20 years of follow-up, and 3) an NCS 
researcher who may need to stratify the study population by levels of risk during analysis 
or follow-up. We compared the requirements we established for a longitudinal study such 
as the NCS with the published requirements for using FHH in an electronic health record 





Evaluation of My Family Health Portrait 
We evaluated the Surgeon General's tool, My Family Health Portrait, in light of 
the requirements we developed. The tool was assessed to determine the domain of 
diseases it addresses, the data collection format, and the severity of unmet criteria. The 
primary author (YJ), who is a PhD student and a previous Preventive Medicine and 
Public Health Practitioner, explored the use of My Family Health Portrait from the 
perspective of a researcher and an NCS participant, determining whether each 
requirement was "met" or "not met."  
Next, we evaluated My Family Health Portrait to determine its usability for the 
target NCS population and to elicit usability requirements. We performed the evaluation 
with five mothers of children under two years of age who resided in Salt Lake County. 
Three mothers were selected by convenience. Two of the mothers were selected using the 
Utah Population Database and Resource for Genetic and Epidemiologic Research, 
University of Utah. The latter two mothers were selected because their children had at 
least three first, second, and third degree relatives that had a preterm birth documented in 
their birth certificate record.  
Two researchers conducted the usability evaluation in each participant’s home 
setting. After obtaining consent, the participants were given tasks that required them to 
use My Family Health Portrait to collect their child’s FHH information. We used a 
naturalistic observation with a “think aloud” technique whereby users talked about what 
they were doing as they interacted with the tool.
21
 The observer provided minimal 
instructions or interruptions and took field notes about the experience.  
26 
 
After the visit, the researchers used a heuristic evaluation method
25
 to determine 
the severity and types of heuristic violations associated with the problems the mothers 
encountered. Both researchers discussed and agreed on the heuristic violation categories 
and assigned severity ratings. If the participant had difficulty recalling particular 
information about relatives, we scheduled a follow-up home visit at the end of the initial 
visit to allow the participant to contact relatives about missing information. This study  







We identified 50 requirements for a tool that may be used to document FHH for a 
longitudinal population-based study such as the NCS (Table 3.1). The requirements were 
classified into six categories: 1) technical requirements; 2) functional requirements for 
collecting, displaying, and storing FHH, including the data to be collected; 3) functional 
requirements for exporting and maintaining FHH in the context of the NCS; 4) usability 
requirements; 5) security requirements; and 6) ethical and legal requirements. The 
relevance of the requirements varied among the three perspectives assessed: a study 
manager, a study participant, and a researcher who would need to use the data to assess 
risk. 
While most of the requirements are self-explanatory, selected requirements may 
need to be highlighted and explained. To meet the needs of a large-scale population-
based study, the tool: 
 should be a self-administered, web-based application to save time and resources. 
 should include definitions of medical terms or only use nonmedical terms. 
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 should allow the user to periodically update their FHH, which will evolve during 
the course of the longitudinal study. This requires that the tool be able to record 
the version used and time stamp each update.  
 should support a context for parents to proxy for their child (the proband) without 
confusion. In most situations involving NCS, a parent will need to fill in the 
information and use the tool for their child. The text and relationships displayed to 
the user should reflect this proxy context. When a family health history tool is 
designed for adult users to collect their own FHH, the user interface will reflect 
the adult's perspective. For example, a typical user interface may include 
questions such as “How many brothers do YOU have?” or “What is this person’s 
relationship to YOU?” If a mother uses the tool from her child’s perspective, the 
current My Family Health Portrait user interface could be confusing if the context 
is not clarified before data collection. If she uses the tool from her own 
perspective, the health history for the paternal side of the child’s family will not 
be collected, though the child’s cousins (i.e., the mother’s nieces and nephews) 
from both the maternal and paternal sides will probably be collected. If both 
parents collect their own history, their nieces’ and nephews’ (e.g., the child’s 
cousins’) information could be duplicated.  
 should address how to store personal identifiers of the family members to enable 
data entry and updates while meeting privacy considerations. Though parents of 
the child consent to participate, the child’s FHH may contain health information 
about the child’s first, second, and even third degree relatives. Obtaining consent 
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from all the relatives is not practical nor may it be necessary because the history is 
being reported for the participants who have consented to participate in the study.  
 should collect sufficient information to generate risk scores for analysis, and 
policies need to be developed to address whether, when, and how this information 
should be shared with study participants. When clear, actionable information is 




In general, the data requirements we defined for documenting FHH for a 
longitudinal population-based study are similar to the data requirements published by 
AHIC for integrating FHH into an electronic health record,
14
 Both sets of requirements 
include data related to the individual's identification, relationship to the proband, gender, 
age, adoptive status, and year of death. While the AHIC requirements included "date of 
death" and "cause of death" in the core data set, we determined that it is also important to 
clearly document the "living status" at the time the history information is gathered. The 
"living status" is especially useful to avoid confusion when the "date of death" and "cause 
of death" are not available. In addition to the data requirements, we defined technical, 
functional, usability, security, and ethical requirements. These additional types of  
requirements were not clearly stated in the requirements published by AHIC.  
 
 
Evaluation of My Family Health Portrait 
 
The My Family Health Portrait tool met 36 (72%) of the 50 requirements we 
defined (see Table 3.1). All the data requirements we identified were met, while the 
functional requirements were less likely to be fulfilled. For example, the tool did not meet 
the following important functional and other requirements:  
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 Requirement 2.6: create a time stamp when the FHH is saved (useful for updating 
family history over time);  
 Requirement 2.7: allow the user to define data sensitivity and data sharing status 
(useful for protecting the participants' privacy);  
 Requirement 4.4: each health condition has a surface form that represents the 
common language used for explaining the concept (useful for the participants to 
understand the concepts and record accurate information); 
 Requirement 4.9: allow researchers to annotate a participant’s record (useful for 
assessing the risk for participants); 
 Requirement 4.7: the user interface should support a context whereby a mother 
can proxy for her child, and the text and relationships should reflect this proxy 
context (useful for collecting complete family history for the child and avoiding 
confusion for the parent). 
The usability of My Family Health Portrait was analyzed by observing use of the 
program by five participants:  the biological mothers of a child living in the same 
household with the child’s father. The mothers were 28 to 42 years of age, had a 
Bachelor’s degree or above, and had regular access to computers and the Internet and 
confidence in their computer and Internet skills. The five participants took 30 to 90 
minutes to enter, view, and print their FHH.  
While entering, viewing, and printing the FHH, we observed 21 usability 
problems (see Table 3.2). Three participants were not able to find a specific disease they 
wanted to document in the drop-down list of diseases provided in the tool. For example, 
to record that a relative has asthma, the user had to open the dropdown list labeled “select 
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disease,” then select “lung disease (more options…),” then open the dropdown list of 
“please specify (lung disease),” then select “asthma.” The users could not find the disease 
because they expected an alphabetic list of diseases or they did not understand that 
asthma was located under the category of lung disease. This problem violated the 
usability heuristics of “Match between the system and the real world: the image of the 
system perceived by users should match the model that the users have about the system” 
and “Visibility of system: users should know what is going on with the application.”25  
In total, the problems we identified violated seven usability heuristics. The most 
frequently violated heuristics concerned the match between the user’s expectation and the 
function of the tool. The second most frequently violated heuristic concerned the 
language used in the tool, which was not always presented in a form understandable to 
the user. None of the violations were catastrophic, requiring that the tool be fixed before 
it could be implemented; however, we identified major and minor violations that should  





FHH reflects shared genetic, environmental and behavioral risks within a family 
that may be important for guiding analyses and interpreting findings from longitudinal 
population-based studies such as the NCS. The limited FHH information collected during 
the pilot phase of the NCS could be enhanced using informatics strategies and tools. Our 
investigation identified requirements for an application to collect, store, and analyze FHH 
data for a longitudinal population-based study and evaluated an existing publicly 
available tool against the requirements. We found that the requirements for documenting 
FHH in an electronic health record
14
 are similar to those required by a longitudinal 
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population-based study, and the Surgeon General's tool meets many but not all of the 
requirements we identified. The recently developed HL7 standards
15
 for modeling and 
messaging family history information and the recent inclusion of “Documentation of 
family medical history” as one of the “Meaningful Use” objectives28 further increase 
opportunities to collect family health histories and reuse already-collected data or build 
upon already-developed tools. To facilitate interoperability between different FHH 
applications, the HL7 Clinical Genomic Work Group is developing a family history 
model that will structure different data elements as attributes of multiples classes for the 
purpose of exchanging family history and genetic tests data, which is beyond the scope of 
this specific study.
15
 But the data requirements we identified are consistent with the 
model that is currently being developed by the HL7 workgroup. All the data elements we 
identified are included in the HL7 family history model, with the exception of the 
"adoptive status" of relatives. We included the adoptive status of the relatives in the data 
requirements for a FHH because it is useful for risk analysis, given that FHH incorporates 
the effects of shared environmental and behavioral factors as well as genetics factors.
2
 
With an added data element of "adoptive status," any application that complies with the 
HL7 FHH standard model should be able to be used to document FHH for risk analysis 
for a longitudinal population-based study.  
Our Study has several strengths. We identified requirements for documenting 
FHH for a longitudinal population-based study, a critical step before expanding data 
collection about FHH among the thousands of study participants that were expected in 
the National Children’s Study. We expanded the data requirements defined by AHIC for 
representing FHH in an electronic health record and personal health record and included 
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requirements that will ensure that risk stratification can be performed.
18,29
 The 
information gathered from the clinical domain experts was used to define the minimum 
degree of relatives and the functional needs for providing an operational definition of a 
health condition. We did not attempt to define the text that should be used, as this would 
require more extensive domain expertise and validation than was possible during this 
study. We identified, however, that a tool must allow for commonly used terms to be 
displayed to the user when they are being asked to consider whether they have family 
members with a particular condition. Finally, we highlighted the relevance of the 
requirements for different users: the study manager, the study participant involved with 
data collection and entry, and the researcher involved in data analysis. This strategy will 
allow the NCS stakeholders to evaluate and validate the requirements we defined in the 
context of their use.  
The requirement analysis may have limitations. In particular, the analysis is 
partially subjective and based on the authors' experience. Even so, the mixed method 
approach to requirements development and iterative development process has strengths.  
For a longitudinal population-based study, the timing of the collection of FHH 
information needs to be considered. No previous publication was identified that addresses 
the effect of the timing of collection of FHH on the quality of the data. FHH evolves over 
time, so the collection of a history is not necessarily required at the beginning of a 
longitudinal study. A complete and up-to-date history should be collected at the end of a 
study.  There is a risk that study participants and their family members may not recall 
events or may not be alive to give a history, which will lead to the loss of some health 
history information. It may be acceptable to initiate the collection of FHH information 
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after the start of a study and update the information periodically and when new health 
events occur. The impact of the timing of collection on the quality of the health history 
needs further research. 
The evaluation of the Surgeon General's My Family Health Portrait tool against 
the 50 requirements revealed strengths and weaknesses in this existing data collection 
tool. The tool did not meet all the requirements, and the major unmet requirements are 
valuable for administrators of longitudinal studies to consider when they select or modify 
tools for their own use. Additionally, the issue of instrumentation biases must be further 
explored and understood. 
The usability assessment uncovered issues that should be addressed by NCS 
before selecting a web-based tool for collecting family history data.  First and foremost, a 
tool should clearly define the context for data collection and documentation in the 
situation when a parent is entering information as a proxy for their child.  Second, the 
tool should allow a user to easily select a health condition and review consumer-friendly 
descriptions for the conditions that are relevant for NCS. Studies have shown that the 
design of a survey instrument plays an important role in self-administered tools,
30,31
 and 
there are two common response formats (radio buttons and drop-down boxes) that are 
often used by online surveys.
32
 My Family Health Portrait used a drop-down box to 
collect a relative's health conditions. While Dillman et al.
33
 suggest that radio buttons are 
favorable as they present questions in a similar way to a conventional paper form, no 
significant differences were found in the completion rate or time to completion between 
radio buttons and drop-down boxes.
32,34
 Other research showed that radio buttons could 





 The same study also used the number of answers that have nonsubstantial values 
as an indicator of data quality and found no significant difference between the data 
quality produced by these two response formats.
35
 Furthermore, no literature was 
identified that addresses how the different formats would affect the accuracy of the self- 
or proxy-reported FHH data. In the context of proxy-reporting of a relative’s health 
history, both formats have strengths and weaknesses. The radio button format explicitly 
steps a user through all the conditions of interest to force them to recall and evaluate the 
status of their relatives. This strategy may improve the sensitivity and specificity for 
documenting conditions among relatives. It may be time-consuming however, especially 
when there are many conditions of interest. The drop-down format is efficient and may 
not need to be updated for different studies, but it may result in users only recording the 
health events that are well known by the user while missing the less “memorable” 
conditions that would need to be sought in a pick list. 
The usability assessment we performed had strengths and limitations. The 
assessment was performed in the participant’s home, which is where most NCS 
participants would input their FHH. On the other hand, the participants may not be 
representative of the NCS study population. The participants were relatively young and 
well educated, with good computer literacy and skills. As a result, we may have missed 
usability problems that would be encountered by those with lower computer literacy and 
skills. Also, the heuristic evaluation method identified heuristic problems but did not 
identify design strengths that should be replicated. In addition, the heuristics evaluation 
relied on the evaluator’s subjective judgment; however, in our evaluation, the two 
observers agreed on the results initially or after discussion. Finally, our enrollment for the 
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usability assessment was lower than expected. We attempted to enroll families from the 
community without an established relationship with the family. Our experience of 
unsuccessful enrollment is not unique as similar challenges face researchers conducting 
clinical trials
36
 and previous studies have examined recruiting barriers.
37
 To alleviate 
recruitment issues in the future, we recommend recruiting participants through health 
care facilities with pre-existing patient relationships and providing incentives to the 
participants to compensate for their time and effort. Despite the limitations, our study 
defined functional and nonfunctional requirements not yet available in the literature, 
evaluated how the national tool met the requirements, and the usability of the national 
tool. In addition, although we only had five participants for the usability assessment, past 
studies have shown that as few as three to six users can detect 80 percent of design  







FHH is an important independent risk factor for many conditions and should be 
systematically collected when performing a longitudinal, population based study of 
health outcomes for diseases that may have a genetic component. The requirements for a 
tool to gather this information are similar to those for gathering FHH for electronic health 
records. We also identified features that should be considered when selecting a tool for 
the NCS. The Surgeon General's My Family Health Portrait tool does not currently meet 
all the requirements, but the developing FHH standards and tools built to those standards 
will meet most of the requirements for tools needed to collect data for longitudinal 




Table 3.1. Requirements for a tool to gather family health histories for a longitudinal 




































Primary justification for the requirement 
1.Technical requirements 
1.1 The tool should be self-
administered, with user instructions 
√ √ N/A To save time and cost for population study 
1.2 The tool should be a computerized, 
web-based application 
√ √ √ Easy access for everyone involved 
1.3 Comply with current terminology 
(such as SNOMED-CT), use 
GEDCOM as family tree structure, 
use HL7 for information model and 
data structure 
√ N/A √ To facilitate family health history data exchange  
2.Functional requirements for collecting, displaying, and storing family health history 
2.1 Allow the user to create a family 
record 
√ √ √ To build the family structure 
2.2 Once a family record is created, 
automatically create an individual 
record for the proband (the child in 
NCS), the proband’s father, and the 
proband’s mother 
√ √ √ To provide the user with the family members of a 
nuclear family to start collecting family health 
history 
2.3  Allow the user to add additional 
individual records to the family 
record by adding relationships 
√ √ √ To provide users the function of adding more 
family members 
2.4 Allow both the family record and 
each individual record to be 
opened, edited, saved, closed, and 
updated when needed  
√ √ √ To provide the functions for recording and editing 
the history throughout the duration of the 
longitudinal study 
2.5 Allow family health history data to 
be stored in the web-based central 
location  
√ √ √ To save the initial and follow-up data  
2.6 Create a time stamp when the 
family health history is saved 
√ √ √ To track the version of the family history and 
compare date of documentation with patient 
enrollment in NCS 
Family record 
2.7 Allow the user to define data 
sensitivity and sharing status 
N/A √ N/A To protect the privacy of the user 
2.8 Allow data entry for the child’s 1st, 
2nd, and 3rd degree relatives  
√ √ √ To cover the required degree of relationship by the  
four NCS diseases  
 2.8.1 Allow data entry for the child’s 1st 
degree relatives 
√ √ √ Parents and siblings are required by all four 
diseases history collection  
 2.8.2 Allow data entry for the child’s 2nd 
degree relatives 
√ √ √ Grandparents, aunts, uncles, nieces and nephews 
are required by obesity, asthma, and autism history 
collection 
 2.8.3 Allow data entry for the child’s 3rd 
degree relatives 
√ √ √ Cousins are required for asthma and autism history 
collection; great grandparents and cousins are 
required for obesity history collection 
2.9 Display the whole family health 
history, either as a spreadsheet or 
pedigree  
√ √ √ To view the big picture of the family health history 
2.10 Allow the user to print the 
spreadsheet or pedigree 
√ √ √ To enable the user to view and share family health 
history  
2.11 Indicate the completeness of 
required data fields 
√ √ √ To save time for continuous collection to complete 
the family record 
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Table 3.1 Continued 
Individual’s record 
2.12 Allow the user to indicate 
consanguinity 
√ √ √ To help interpret the risk evaluation 
2.13 Allow unknown values for each 
data field except “name” and “year 
of birth”  
√ √ √ Name is needed for the user to identify family 
members, year of birth is needed for generating risk 
assessments 
2.14 Allow text for explaining medical 
terms for lay people 
N/A √ N/A To avoid user confusions 
2.15 Allow the user to indicate the level 
of certainty for each health 
condition field 
√ √ √ To record users’ different level of certainty for 
recalled information 
2.16 Each person’s data sheet should 
contain a textbox for annotations  
√ √ √ To record additional information 
2.17 Allow the user to print a paper 
version with all fields whether they 
are filled or not  
N/A √ N/A To enable users to use the unfilled paper version for 
data collection, the filled version for sharing 
2.18 Each individual’s data collection 
sheet should include the following 
individual’s identifiers and 
demographic data  
√ √ √ These are the basic data fields that should be 
included for family health history collection and use 
it for  risk assessment 
 2.18.1 Individual’s record identifier 
automatically assigned by the 
system 




Name N/A √ N/A For the users to identify the relative for data entry 
 2.18.3 Relationship to the proband √ √ √ To build the family pedigree 
 2.18.4 Gender √ √ √ To identify the individual and to be used for the risk 
assessment  
 2.18.5 Year of birth √ √ √ To identify the individual and to be used for the risk 
assessment 
 2.18.6 Living status  √ √ √ To be used for the risk assessment  
 2.18.7 Year of death √ √ √ To be used for the risk assessment 
2.18.8 Adoptive status √ √ √ To be used for the risk assessment 
2.19 Each individual data record should 
allow users to document the 
presence of none to many health 
conditions  
√ √ √ To collect health condition information for the risk 
assessment 
 
 2.19.1 Health condition (including pre-
term birth, obesity, asthma, and 
autism) 
 
√ √ √ To be used for the risk assessment  
*Clinicians may collect the history of both mother 
giving birth to a preterm baby and the person born 
prematurely. We here only document the history of 
the person who was born prematurely 
 2.19.2 Year of onset  √ √ √ To be used for the risk assessment 
3.Functional requirements for exporting, using, and maintaining of family health history in the context of NCS 
data management 
3.1 Export file in a structured and coded 
format that can be translated into 
HL7 standard code sets when it is 
stored for the NCS 
√ N/A √ NCS needs standardized data for data storage and 
exchange 
3.2 Allow data to be extracted for risk 
assessment 
 
√ N/A √ To enable risk assessment based on the family 
health history data collected 
3.3 
 
Allow the user to update histories 
periodically over time 
√ √ √ To enable data collection over years  
3.4 Allow the user to save different 
versions of family history data  
√ √ √ To enable view and compare different versions of 




Table 3.1 Continued 
4.Usability requirements 
For participants 
4.1 Friendly interface that complies 
with the ISO usability standard 
(ISO 9241) 
N/A √ N/A To facilitate the human-computer interaction 
4.2 All text and instructions in the 
application should be written to a 
6th grade reading level or lower 
N/A √ N/A To meet the needs of users who have different 
levels of education, literacy… 
4.3 When the user logs in, the system 
should display a welcome message 
with the user’s name, and bring the 
user to the “family record” by 
default 
N/A √ N/A To ease data input 
4.4 Each health condition has a surface 
form that represents the common 
language used for the concept 
N/A √ N/A To use user’s language and avoid confusion 
4.5 Display additional text explaining 
each health condition that is the 
interest of the study.  
N/A √ N/A To help users understand medical terms. For 
example, the text explaining preterm birth may be 
“Birth less than 37 weeks of gestational age or 21 
days or more earlier than the due date”; the text 
explaining autism may be “autism spectrum 
disorder, including autism, Asperger, and POD-
NOS”) 
4.6 Display error messages properly N/A √ N/A To ease the data input 
4.7 The user interface should support a 
context whereby a mother can 
proxy for her child (the proband), 
and the text and relationships 
should reflect this proxy context. 
i.e, ask “relationship to child” rather 
than “relationship to me” 
N/A √ N/A To avoid user confusions which could lead to 
incomplete data collection  
For study managers and researchers 
4.8 Replicate participants’ view  √ N/A √ To facilitate the risk assessment process 
4.9 Allow users to annotate a 
participant’s record 
√ N/A √ To facilitate the risk assessment process 
5.Security requirements 
5.1 Store family health history data 
securely and confidentially 
√ √ √ To protect the participants’ privacy and data 
security 
5.2 User authentication and 
authorization, only authorized users 
have access 
√ √ √ To protect the participants’ privacy and data 
security 
5.3 Log users out after a pre-specified 
period of inactivity (e.g., ~30 
minutes) 
N/A √ N/A To protect the participants’ privacy and data 
security 
6.Ethical and legal requirements 
6.1 Each individual has an unique 
identifier so when records are 
exported to the NCS for analysis, 
non-consenting relatives can be de-
identified by excluding the individual 
names from the records 
√ N/A √ To protect the user’s privacy. There are 18 specific 
identifiers need to be removed according to 
HIPAA “safe harbor” method. Name is one of the 
18 identifiers  being required to collect by NCS 
6.2 Requirement for observational study: 
do not report risk assessment to the 
users unless actionable information is 
obtained about  significant health 
risks 
N/A √ N/A NCS is a pure observational study; communication 
risk to the users introduces interventions.  
N/A = not applicable 
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Table 3.2. Summary of usability violations observed during use of My Family Health 
Portrait to collect family history for the NCS, 2010 




severity  Adding first relative  User was not sure from whose (her self’s or her child’s) perspective 




User skipped the “living status” question; thus, the tool did not 




User indicated that a person was dead, then no birth date 





After the user made a mistake of using the wrong format of birth 
date, an error message displayed and previous entered data of race 
and ethnicity were lost.  
Undo Major 
Looking at the disease 
list 





asthma history  
User did not find asthma in the disease list, so she entered “asthma” 







User could not locate preterm birth from the dropdown list and did 
not know there was an option to enter free text   
Match Major 
Saving family history The process took longer than 30 seconds; user had to use another 
option (click “select the link”) to save history. 
Feedback Major 
Printing family history “Preterm birth” and “Preterm Birth” were printed as different 
conditions  
Match Major 
Entering number of 
relatives 





User had to choose only one of the three ways (full birth date, age, 
or estimated age) to enter birth date.  The user was trying to enter 






Entering child’s weight 
& height 
User was not sure whether the 'weight & height' was referring to 




The tool only allowed one death cause and the user wanted to input 




User was not sure about the definition of preterm birth Language Minor 
Entering relative’s 
asthma history 
After a user typed “asthma”, an error message showed up: “Stack 












A button marked “add” needs to be clicked to save a relative’s 
condition. The user was not sure about the function of the button 
but she tried it anyway.  
Language Cosmetic 
Adding a cousin User could not find how to add a cousin Visibility Cosmetic 
Entering relative’s 
estimated age 
User was not sure about the definition of “in infancy” so defined it 
using her own definition as “less than 2 years old” 
Language Cosmetic 
Opening saved family 
history 
The “browse” and “open” buttons must be clicked in specific order. 





Entering relative’s race 
and ethnicity 
User was not aware of the difference between race and ethnicity Language Cosmetic 
Key: Description of usability heuristics (Zhang, et al., 2003): 
 Match between the system and the real world: the image of the system perceived by users should match the model 
the user have about the system. Also, assess the fit of the device with the kind of work that is being done; 
 Reversible actions (undo): users should be allowed to recover from errors; 
 Visibility of System State: users should know what is going on with the device or application; 
 Informative Feedback: prompt, informative feedback about actions; 
 Use the Users’ Language: the language should be always presented in a form understandable by the users; 
 Flexibility and efficiency: users need flexibility for shortcuts, customization; 
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QUALITY ASSESSMENT OF THE DISEASE AND RISK 
 
FACTOR DATA AND RATES GENERATED 
 





Self-administered questionnaires are frequently used in population-based studies 
to obtain information about study subjects.
1
 In current public health practice and 
epidemiology studies, questionnaires are often used to collect health related information
2
 
including family health history (FHH). FHH uses genetic relationships and the medical 
history of a family to assess each family member’s risk of disease.3 To record an 
individual’s FHH, the informant needs to not only report on his or her own medical 
history (self-report) but also report on his or her first, second, or even third degree 
relative’s medical history (proxy-report).4,5 The accuracy of self- and proxy- reported 
FHH information remains unclear. According to a systematic review from a National 
Institute of Health conference in 2009, the accuracy of reporting FHH varies based on the 
disease being studied.
6
 In general, correct reporting of the absence of disease in relatives 
was better than correct reporting of the existence of disease.
6
 The results from multiple 
studies showed that the specificities of reporting family history of cancer were high, 
ranging from 0.91 to 1.00. In contrast, the sensitivities reported in these studies varied by 
the type of cancer: breast, 0.72 to 0.95; colon: 0.33 to 0.90; ovarian, 0.42 to 0.38; and  
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prostate, 0.47 to 0.79.
6
 Similar patterns were observed when reporting family history of 
other diseases such as diabetes, hypertension, and cardiovascular disease: the specificities 
were high, ranging from 0.76 to 0.98, while the sensitivities varied from 0.18 to 0.89.
6
 No 




The Health Family Tree program was initially developed by researchers in Utah 
and Texas in the early 1980s.
7
 From 1983 to 2001, researchers collaborated with schools 
and distributed a paper questionnaire as a take-home assignment for high school students 
in Utah through their required Health Education class. The questionnaire (Figures 4.1 and 
4.2) was used to document information about common diseases and general lifestyle risk 
factors about family members.
8
 Students were instructed to finish the assignment with 
help from their parents. Then the content of the paper questionnaire was transferred onto 
a scan form, scanned, and stored in the computer-based Health Family Tree database. 
The family members included the student’s siblings, parents, aunts and uncles, and 
grandparents.  
The information collected about each individual by the Health Family Tree 
questionnaire can be categorized into three sets of information. The first set of 
information concerned demographic characteristics, including year of birth, sex, age 
(now or at death), living status causes of death, and blood relationship with the student or 
not. The second set of information concerned diseases and health conditions, including 
diabetes, myocardial infarction (MI), coronary heart disease (CHD), stroke, high blood 
pressure, high blood cholesterol, breast cancer, lung cancer, and colon cancer. The third 
set of information concerned lifestyle risk factors, including smoking, overweight/obese, 
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drinking, and exercise. The questions used to gather the disease and risk factor 
information are described in Table 4.1.  
In 1986, an accuracy study was performed to assess the quality of the information 
reported about CHD by the students and their parents.
9
 A subset of the families was 
selected and the family members were contacted to confirm the reported disease status 
using a mailed questionnaire with additional questions, a phone call, or a personal 
interview. Results showed the sensitivity of capturing CHD events was 67% and the 
specificity was 96%.
9
 These performance measures are high but within the range of 
performance measures reported in other studies.
6
 
The above accuracy study and other accuracy studies included in the National 
Institute of Health review used similar methods to verify a relative’s actual disease status. 
They either directly contacted the individual associated with the information, reviewed 
medical records, or reviewed disease or death registries. These methods require locating 
each relative’s records or interviewing the relative. While these methods directly capture 
the relative’s history from an authoritative source or the person themselves (i.e., self 
report), there are several disadvantages. In particular, these methods are resource- and 
time-intensive because the verification process requires finding existing records or 
contacting multiple relatives. These methods may be justified when validating an 
individual’s outcome and risk information needed to document ‘observed’ events within 
a single family; however, they may not be needed to determine the validity of self- and 
proxy-reported data to generate ‘expected’ rates in a prediction algorithm. Population-
based rates of disease and risk factors may be derived from cancer registries (which are 
highly sensitive and specific) and from standardized public health survey interviews of 
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individuals who self-report their health status. The relationship between the self- and 
proxy- reported information in the Health Family Tree and information from these public 
sources is unknown.  
There are several reasons to assess the quality of the self- and proxy-reported 
family health history information reported in the Health Family Tree. First, biases are 
known to be present when reporting FHH,
6
 but the magnitude and direction of differences 
between self- and proxy-reported information is not known. Second, these differences 
may impact the interpretation of risk algorithms based on self- and proxy-reported data. 
Therefore, the objective of this study was to compare the disease and risk factor rates 
generated from the Health Family Tree database of self- and proxy-reported family health  







Between 1983 and 2001, 57,238 high school students distributed throughout 
northern Utah completed a family health history. All records in the Health Family Tree 
database were candidates for this analysis, including 1,195,599 individuals’ self- or 
proxy- reported medical history and lifestyle risk factors. The individuals may be 
represented twice, if more than one student from a single family participated in the class 
assignment. Prior to analyzing the data, we systematically checked all variables for errors 
and missing values. After cleaning, 1,021,909 (85.5%) valid records remained. We 
defined and handled errors and missing values in the following manner:  
 When “age” was missing for “living” relatives, we calculated age using the 
reported year of birth.  
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 When there was a mismatch between the reported “sex” of the family member 
and the type of relative (i.e., grandmother should be a female), we used the 
relationship defined on the Health Family Tree (i.e., used the “relative 
number”) to assign a value for ‘sex.’ For example, relative number 4 and 
number 6 are grandmothers of the high school student and their “sex” should 
be “female,” and never “male.”  
 Records with more than four reasons of death were removed from the analysis 
assuming that they were errors. 
 Records for parents of a high school student that report an age less than 25 
years were removed from the analysis. 
 Records with an invalid or uncorrectable “sex,” “age,” “relative number,” or  
“year of birth” were removed from the analysis. 
 
 




To compare the rates generated by the Health Family Tree with rates available 
from public data sources, we calculated rates from the Health Family Tree database. All 
diseases and risk factors were included except MI, drinking, and being overweight/obese. 
We did not identify any public data source that used definitions of drinking and 
overweight/obesity that were similar to those used by the Health Family Tree, and we 
were unable to find public data sources concerning MI in the time periods addressed by 
Health Family Tree (Table 4.2). We limited the Health Family Tree data to time periods 
that matched or were similar to the time frames of the available public data (Table 4.2). 
For diabetes, high blood pressure, high blood cholesterol, breast cancer, lung cancer, 
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colon cancer, and smoking, we selected the time period from 1990 to 1999. All records 
that were collected between 1990 and 1999 for persons that were alive at the time of data 
collection constituted the sample for the rate comparison for these diseases or risk factor. 
For CHD and stroke, we calculated rates based on information collected in 1996 because 
the public population-based data for Utah were only available for that year. For exercise, 
we generated rates of exercise using the latest five years (1997-2001) of data in the 
Health Family Tree database. Public data for Utah about exercise was only available for 
2001, 2003, 2005, 2009, and 2010. The 2001 data alone was an insufficient sample, so 
we used data for all the years in the comparison.  
We compared either incidence or prevalence rates depending on the available 
rates reported from public sources. For example, the public data available for cancers 
allows for the calculation of incidence rates, thus incidence rates were used for 
comparing cancer rates. All other diseases and risk factors were only reported as 
prevalence rates in the public data sets, thus prevalence rates were used for comparing 
noncancer diseases and risk factors. The following public data sources were used for the 
analysis: 
 We obtained the prevalence rates from 1990-1999 of diabetes, high blood 
pressure, high blood cholesterol, smoking, and exercise from the Behavioral 
Risk Factor Surveillance System (BRFSS)
10
 using the online portal of Utah's 
Indicator-Based Information System for Public Health.
11
  
 We obtained prevalence rates for 1996 of CHD and stroke from the Utah 
Healthcare Access Survey (UHAS)
12
 with assistance from analysts at the Utah 
Department of Health. 
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 We obtained incidence rates from 1990-1999 of breast, lung, and colon cancer 
from the Utah Cancer Registration (UCR)
13
 using the SEER*Stat tool.
14
 
We graphed the rates from each data source for each disease and risk factor to 
compare the magnitude of the rates and the pattern by sex and age group. We used the 
Cochran-Mantel-Haenszel statistic to test the significance of differences in the rates, as 
the Cochran-Mantel-Haenszel statistics are a collection of tests analyzing categorical data 
while controlling for covariates. We also used the chi-square test to examine 
disagreement for each sex- and age-subgroup. We also compared the rates reported by 
public data sources with the rates generated by the Health Family Tree stratified by 
proxy- versus self-report. Records concerning the students or their siblings and parents 
were classified as self-reported, as the parents were supposed to help the student fill out 
the questionnaire. Records concerning the student’s aunts and uncles and grandparents 
were classified as proxy-reported. 
The Health Family Tree computer-based program and SAS 9.2
15
 were used to 
calculate and compare the rates. This study was reviewed and approved by the  







A total of 1,021,909 valid records were available from students that participated in 
the Health Family Tree school assignment from 1983 to 2001. The demographic 
distribution of the records is shown in Table 4.3. About one-third (32.8%) of the records 
were for the students or their siblings and parents (which we classified as self-reported). 
The remaining two-thirds of the records were for the student’s aunts and uncles and 
50 
 
grandparents (which we classified as proxy-reported). The proportion of records for 
students, mothers, fathers, maternal grandmothers, maternal grandfathers, paternal 
grandmothers, and paternal grandfathers were similar (5%-6% each). The proportion of 
records for student's siblings, maternal aunts and uncles, and paternal aunts and uncles  
were higher (14%-22%). 
 
 




The Health Family Tree and public data sources have similar patterns of rates by 
age and sex groups (Figure 4.4). For example, the rates of all diseases increased with age, 
smoking rates are higher in the middle age groups, and exercise rates decrease with age. 
The agreement between rates generated by subjects in the Health Family Tree and public 
data varied across disease categories (Table 4.4). There was no significant difference in 
the rates reported for stroke (Cochran-Mantel-Haenszel (CMH) p = 0.18 overall, and p = 
0.1 for self- and proxy-reported subjects), for self-reported breast cancer (p = 0.08) and 
lung cancer (p = 0.25), and for proxy-reported diabetes (p = 0.05)). However, for all other 
comparisons shown in Table 4.4, there was a significant difference in the rates reported in 
the Health Family Tree and the public data sources (p < 0.05). While there are 
exceptions, the low agreement was primarily due to underreporting of events in the 
Health Family Tree compared with events reported in public data sources (Tables 4.5-
4.14; subgroup chi-square p < 0.05). Of the underreported diseases, high blood pressure 
and high blood cholesterol were severely underreported. Only a few sex- and age-specific 
groups reporting CHD (male 60-69 age group: mixed and proxy-reported), stroke (male 
60-69 age group: mixed and proxy-reported), breast cancer (female 20-29 age group: 
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mixed, self-, and proxy-reported), lung cancer (male 20-29 age group: mixed, self-, and 
proxy-reported), and colon cancer (male and female 20-29 age groups: mixed, self-, and 
proxy-reported) in Health Family Tree yielded significantly higher rates than public 
sources (Tables 4.5-4.14; subgroup chi-square p values < 0.05). These over-reported 
subgroups were either the oldest (60-69) or youngest (20-29) age groups.  
A comparison of self-reported information and proxy-reported information again 
showed variation. Both self-reported and proxy-reported rates, in comparison with public 
data, a) underreported diabetes, CHD, high blood pressure, high blood cholesterol, colon 
cancer, and smoking; b) reported stroke at a rate similar to the public data; and c) over-
reported exercise rates. When comparing reported and public data for breast and lung 
cancer, the rates for self-reporting a history of breast cancer and lung cancer were not 
significantly different from the rates recorded in the public data. Proxy-reported rates of 
these two cancers were significantly lower than rates from public data sources, which 
caused the combined self- and proxy-reported rates to be significantly lower. 
Furthermore, though both self- and proxy-rates of high blood pressure and high blood 
cholesterol were significantly lower than public data, self-reported rates were higher than 
proxy-reported rates and were closer to the public rates. Conversely, self-reported rates 
for smoking were lower than proxy-reported rates and were more underreported in 
comparison with rates from public data sources. Self-reported rates of exercise were 





Family health history is an important independent risk factor that may be used in 
the prediction of certain chronic diseases. Most family health history data are self- or 
proxy-reported; therefore, it is valuable to assess the accuracy of this type of data prior to 
its use in clinical and public health decision-making. Previous research focused on 
comparison of patient self-reports with medical records at the individual level. In the 
current analysis, we used a different approach to examine the data accuracy, comparing 
population prevalence and incidence rates generated from the self- and proxy-reported 
Health Family Tree database with the corresponding rates generated from authoritative 
public data sources, such as cancer registries and standardized public health surveys.  
We used the unique Health Family Tree database and extracted rates for different 
diseases and risk factors, stratified by sex and age groups from the database. We then 
compared the extracted rates with the public rates. We found that the disease and risk 
factor rates have similar patterns by sex and age as population rates reported in public 
data sources but were statistically significantly different, and generally lower than the 
population rates. One exception was reported exercise rates, which were higher than 
exercise rates reported in the public data set. 
The comparison also showed that for different diseases and risk factors, the age- 
and sex-distribution showed similar patterns but agreement about the rates of the health 
events varied: the rates reported were similar for stroke but were significantly different 
for other diseases. Most of the diseases (and smoking behavior) included in the 
comparison study were underreported in the Health Family Tree database when 
compared to public data. On the other hand, exercise was overreported in the Health 
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Family Tree database. This analysis helped us to pinpoint the accuracy of FHH in terms 
of particular diseases and related disease behaviors. For example, more salient events 
such as stroke may be recalled better by the informants than other chronic conditions 
such as high blood pressure and high blood cholesterol, while protective factors (i.e., 
negative risk factors) such as exercise were estimated to be higher than the rates found in 
public data sources. Furthermore, self- and proxy-reported data were similar when 
reporting most of the diseases and the two lifestyle factors; however, they differed when 
reporting breast cancer and lung cancer (self-reported is accurate while proxy-reported is 
low).  
There may be limitations in this study. The Health Family Tree population 
represents the northern Utah population while the standardized public health surveys and 
cancer registry represent the state population. The impact of this difference is likely 
minimal because approximately 80% of Utah residence live along the Wasatch Front in 
the northern part of the state.
16
 The Health Family Tree data were collected from 1983 to 
2001, so the major disease events in the database could have occurred during the early to 
late part of 20th century. We tried to address this issue by using the disease events that 
happened within time periods comparable to the available public population data sources. 
Finally, and most importantly,  the questions used to ascertain information about diseases 
and risk factors in the Health Family Tree are not worded exactly the same as the 
questions used to gather information for the public data sources. For example, in the 
Health Family Tree, CHD was defined as answering "yes" to "Has he/she ever been told 
by a doctor that he/she suffers from" either "heart attack" or "coronary bypass surgery." 
In the UHAS, CHD was defined as answering "yes" to "Has a medical doctor or other 
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medical professional ever told you (him/her) that you (they) have heart disease, such as 
angina, congestive heart failure, or heart attack?"  The difference in wording could lead 
to a significant difference in reporting. The term “suffer” may lead respondents to believe 
that the question is about their (dis)ability to respond to a medical condition (in other 
words, whether the condition is causing them to suffer or not). Furthermore, UHAS 
queried for more conditions (i.e., angina) when asking about CHD than were used by the 
Health Family Tree. This may explain the underreported rates of CHD in the Health 
Family Tree database. Similarly, vigorous exercise was defined more strictly in BRFSS 
than the Health Family Tree: "Vigorous exercise at least 3 times for 20 minutes per 
week" (BRFSS) vs. "Vigorous routine exercise at least 3 times per week" (Health Family 
Tree). This difference may explain the overreported rates of exercise in the Health 
Family Tree database. Though we only included the diseases and risk factors for which 
we could find similar definitions in the public data sources and excluded the ones that did 
not match (overweight/obesity, drinking), to what extent the rate of under- or 
overreporting was due to the different questions remains unknown. Despite existing 
limitations, the accuracy examination provides information about the quality of the self- 
and proxy-reported FHH data and hence should be considered when using these data for 
risk assessment.  
Besides the questionnaire and database, another component of the Health Family 
Tree program is an algorithm to predict risk. This algorithm predicts risks based on the 
comparison between the number of observed events and expected events within each 
family. The number of expected events was calculated from the disease rates generated 
from the database itself. The expected events will be underestimated when the population 
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is underreporting events. The underestimated expected events will lead to an 
overestimated risk as the risk algorithm compares observed events (numerator) to 
expected events (denominator). The overestimated risk will categorize more people in the 
higher risk group and increase the chance of applying more strict screening strategies. In 
most public health screening strategies, this outcome is acceptable since the cost of 
screening healthy individuals is much lower than the treatment of affected patients. 
Persons identified as higher risk by a FHH-based tool may be provided with health 























































































































































































Figure 4.2. The questionnaire box containing questions asked for each family 





Figure 4.3 Disease and risk factor prevalence (%) or incidence rates (‰) generated 
from the Health Family Tree (HFT) database and the rates reported by public data 
sources including Utah Cancer Registry (UCR), Utah Behavioral Risk Factor 




Table 4.1. Diseases and lifestyle risk factors collected by the Health Family Tree 
Disease/Risk 
factor 
Question/Instruction to the informants Value 
Diabetes Has he/she ever been told BY A DOCTOR that he/she 




Has he/she ever been told BY A DOCTOR that he/she 




Has he/she ever been told BY A DOCTOR that he/she 
suffers from heart attack or coronary bypass surgery? 
Yes/No/Not sure 
Stroke Has he/she ever been told BY A DOCTOR that he/she 




Has he/she ever been told BY A DOCTOR that he/she 




Has he/she ever been told BY A DOCTOR that he/she 
suffers from high blood cholesterol? 
Yes/No/Not sure 
Breast cancer Has he/she ever been told BY A DOCTOR that he/she 
suffers from breast cancer? 
Yes/No/Not sure 
Lung cancer Has he/she ever been told BY A DOCTOR that he/she 
suffers from lung cancer? 
Yes/No/Not sure 
Colon cancer Has he/she ever been told BY A DOCTOR that he/she 




Has smoked cigarettes regularly for at least 1 year Smoker 
 Stopped for at least one year after smoking regularly Ex-smoker 
 Never smoke cigarettes regularly Non-smoker 
 Usual weight Your opinion based on the person's usual weight Slender or average/10-49 
lbs. overweight/50-99 lbs. 





Drinking some type of alcohol (beer, wine, liquor) 3 or 





Vigorous routine exercise at least 3 times per week. 
"Vigorous routine exercise" means the exercise that 
raises your heart rate and increases breathing for about 
half an hour or more without interruption. Jogging, 




Table 4.2. Diseases and risk factors that were included in the rates comparison 
between the Health Family Tree program and public data sources 
 Health Family Tree (HFT) Public data sources 
 Data source 
& year  






"Yes" to "Has 
he/she ever been 
told by a doctor 
that he/she 





were queried in 
the term as they 
are in the first 
column except 
CHD. CHD was 
defined as "yes" 
to either "heart 
attack" or 
"coronary 
bypass surgery"   
BRFSS 
1990-1999 
"Yes" to "Have you ever been 








"Yes" to "Has a medical doctor or 
other medical professional ever 
told you (him/her) that you (they) 
have heart disease, such as 
angina, congestive heart failure, 





"Yes" to "Has a medical doctor or 
other medical professional ever 
told you (him/her) that you (they) 







"Yes" to "Have you ever been 
told by a doctor, nurse, or other 








"Yes" to "Have you ever been 
told by a doctor, nurse, or other 
professional that you r blood 
cholesterol is high?" 




Indicated as "breast cancer" in the 
registry  




Indicated as "lung cancer" in the 
registry 












regularly for at 
least 1 year." 
BRFSS 
1990-1999 
"Every day" or "Some days" to 
"Do you now smoke cigarettes 
every day, some days, or not at 
all?" AND who had smoked ≥100 






at least 3 times 





Vigorous exercise at least 3 times 
for 20 minutes per week 
* The HFT program included a description of the diseases queried by the tool. 











Table 4.3. Demographic distribution of records in the 
Health Family Tree database collected from 1983 to 2001 
 Male Female 
Age in years Number (%) Number (%) 
<20 71,764(7.0) 69,700(6.8) 
20-29 49,283(4.8) 45,348(4.5) 
30-39 89,053(8.7) 96,903(9.5) 
40-49 126,349(12.4) 118,347(11.6) 
50-59 62,949(6.2) 57,716(5.7) 
60-69 54,819(5.4) 60,866(6.0) 
>70 59,708(5.8) 58,104(5.7) 








Table 4.4. Significance of the difference in disease and risk factor rates from the 
Health Family Tree and selected public data sources 
  
 
P values from Cochran-Mantel-Haenszel test 
 All subjects Self-reported subjects 
(students, siblings, and parents) 
Proxy-reported subjects 
(grandparents, aunts and uncles) 
Diabetes 0.02 <0.01 0.05 
Coronary 
heart disease 
0.01 <0.01 0.03 
Stroke 0.18 0.11 0.10 
High blood 
pressure 
<0.01 <0.01 <0.01 
High blood 
cholesterol 
<0.01 <0.01 <0.01 
Breast cancer <0.01 0.08 <0.01 
Lung cancer <0.01 0.25 <0.01 
Colon cancer <0.01 <0.01 <0.01 
Smoking <0.01 <0.01 <0.01 
Vigorous 
exercising 










Table 4.5. Diabetes (DM) counts and prevalence from two data sources: Behavioral 
Risk Factor Surveillance Survey (BRFSS); Health Family Tree (HFT) 
Sex Age DM 











Counts Prevalence  Counts Prevalence Counts Prevalence Counts Prevalence 
Male 20-29 Yes 11 0.54  140 0.70 79 0.59 61 0.92 
  No 2152   19833  13253  6580  
 30-39 Yes 36 1.59  515 1.34 105 1.54 410 1.30 
  No 2432   37938  5728  31210  
 40-49 Yes 57 2.95  1289 2.22 440 2.31 849 2.18** 
  No 1943   56725  18580  38145  
 50-59 Yes 70 5.93  1256 4.94 252 4.65 1004 5.02 
  No 1179   24144  5163  18981  
 60-69 Yes 108 10.58  2150 10.09 50 9.14 2100 10.12 
  No 902   19151  497  18654  
Female 20-29 Yes 31 1.06  168 0.88 97 0.76** 71 1.14 
  No 2663   18878  12708  6170  
 30-39 Yes 44 1.21  688 1.65 200 1.79 488 1.60 
  No 3081   41057  10956  30101  
 40-49 Yes 71 2.51  1312 2.35 404 2.23** 908 2.42 
  No 2371   54404  17746  36658  
 50-59 Yes 103 7.48  1185 4.92** 101 3.32** 1084 5.15** 
  No 1476   22895  2945  19950  
 60-69 Yes 121 8.90  2410 9.49 13 7.26 2397 9.51 
  No 1208   22977  166  22811  
Mantel Haenszel p value     0.02  <0.01  0.05 
 










Table 4.6. Coronary heart disease (CHD) counts and prevalence from two data 
sources: Utah Healthcare Access Survey (UHAS); Health Family Tree (HFT) 
Sex Age CHD 











Counts Prevalence  Counts Prevalence Counts Prevalence Counts Prevalence 
Male 20-29 Yes 5 0.41  3 0.14 2 0.13 1 0.16 
  No 1218   2126  1510  616  
 30-39 Yes 5 0.36  17 0.46 2 0.30 15 0.49 
  No 1374   3700  672  3028  
 40-49 Yes 23 1.83  106 1.70 37 1.88 69 1.61 
  No 1231   6144  1926  4218  
 50-59 Yes 56 7.09  179 6.48 29 5.01 150 6.86 
  No 734   2585  550  2035  
 60-69 Yes 97 15.59  418 19.75** 10 15.38 408 19.89** 
  No 525   1698  55  1643  
Female 20-29 Yes 2 0.14  7 0.35 5 0.35 2 0.34 
  No 1405   2000  1421  579  
 30-39 Yes 9 0.65  11 0.26 6 0.53 5 0.17** 
  No 1377   4154  1135  3019  
 40-49 Yes 21 1.63  25 0.42** 7 0.39** 18 0.44** 
  No 1270   5905  1804  4101  
 50-59 Yes 39 4.81  68 2.60** 5 1.39** 63 2.80** 
  No 771   2546  356  2190  
 60-69 Yes 67 9.83  151 5.96** 1 5.88** 150 5.96** 
  No 615   2383  16  2367  
Mantel Haenszel p value     0.01  <0.01  0.03 










Table 4.7. Stroke counts and prevalence from two data sources: Utah Healthcare 
Access Survey (UHAS); Health Family Tree (HFT) 
Sex Age Stroke 











Counts Prevalence  Counts Prevalence Counts Prevalence Counts Prevalence 
Male 20-29 Yes 0 0  2 0.09 0 0.00 2 0.32 
  No 1222   2127  1512  615  
 30-39 Yes 2 0.15  10 0.27 1 0.15 9 0.30 
  No 1377   3707  673  3034  
 40-49 Yes 7 0.56  20 0.32 5 0.25 15 0.35 
  No 1249   6230  1958  4272  
 50-59 Yes 13 1.65  45 1.63 8 1.38 37 1.69 
  No 777   2719  571  2148  
 60-69 Yes 17 2.73  124 5.86** 3 4.62 121 5.90** 
  No 606   1992  62  1930  
Female 20-29 Yes 2 0.14  4 0.20 2 0.14 2 0.34 
  No 1406   2003  1424  579  
 30-39 Yes 7 0.51  8 0.19 2 0.18 6 0.20 
  No 1379   4157  1139  3018  
 40-49 Yes 9 0.70  22 0.37 8 0.44 14 0.34 
  No 1284   5908  1803  4105  
 50-59 Yes 14 1.73  45 1.72 5 1.39 40 1.78 
  No 796   2569  356  2213  
 60-69 Yes 22 3.23  99 3.91 0 0.00 99 3.93  
  No 659   2435  17  2418  
Mantel Haenszel p value     0.18  0.11  0.10 










Table 4.8. High blood pressure (HBP) counts and prevalence from two data sources: 
Behavioral Risk Factor Surveillance Survey (BRFSS); Health Family Tree (HFT) 
Sex Age HBP 











Counts Prevalence  Counts Prevalence Counts Prevalence Counts Prevalence 
Male 20-29 Yes 123 8.31  276 1.38 157 1.18 119 1.79 
  No 1358   19697  13175  6522  
 30-39 Yes 219 13.08  1862 4.84 487 7.13 1375 4.35 
  No 1455   36591  6346  30245  
 40-49 Yes 275 20.24  5578 9.61 2257 11.87 3321 8.52 
  No 1084   52436  16763  35673  
 50-59 Yes 237 28.52  4300 16.93 1122 20.72 3178 15.90 
  No 594   21100  4293  16807  
 60-69 Yes 294 42.00  5586 26.22 148 27.06 5438 26.20 
  No 406   15715  399  15316  
Female 20-29 Yes 153 8.33  207 1.09 124 0.97 83 1.33 
  No 1682   18839  12681  6158  
 30-39 Yes 235 10.74  1400 3.35 460 4.12 940 3.07 
  No 1954   40345  10696  29649  
 40-49 Yes 294 18.04  3689 6.62 1273 7.01 2416 6.43 
  No 1336   52028  16877  35150  
 50-59 Yes 352 32.84  3572 14.83 474 15.56 3098 14.73 
  No 720   20508  2572  17936  
 60-69 Yes 379 42.73  6678 26.30 41 22.91 6637 26.33 
  No 508   18709  138  18571  
Mantel Haenszel p value     <0.01  <0.01  <0.01 










Table 4.9. High blood cholesterol (HBC) counts and prevalence from two data 
sources: Behavioral Risk Factor Surveillance Survey (BRFSS); Health Family Tree 
(HFT) 
Sex Age HBC 











Counts Prevalence  Counts Prevalence Counts Prevalence Counts Prevalence 
Male 20-29 Yes 67 5.16  315 1.58 195 1.46 120 1.81 
  No 1231   19658  13137  6521  
 30-39 Yes 165 11.23  1753 4.56 501 7.33 1252 3.96 
  No 1304   36700  6332  30368  
 40-49 Yes 249 20.77  5496 9.47 2689 14.14 2807 7.20 
  No 950   52518  16331  36187  
 50-59 Yes 210 28.15  3432 13.51 1024 18.91 2408 12.05 
  No 536   21968  4391  17577  
 60-69 Yes 189 30.14  4018 18.86 115 21.02 3903 18.81 
  No 438   17283  432  16851  
Female 20-29 Yes 84 5.20  255 1.34 164 1.28 91 1.46 
  No 1530   18791  12641  6150  
 30-39 Yes 197 10.23  1377 3.30 526 4.71 851 2.78 
  No 1728   40368  10630  29738  
 40-49 Yes 270 18.63  3363 6.04 1435 7.91 1928 5.13 
  No 1179   52353  16715  35638  
 50-59 Yes 268 28.03  2520 10.47 410 13.46 2110 10.03 
  No 688   21560  2636  18924  
 60-69 Yes 298 37.82  4341 17.10 31 17.32 4310 17.10 
  No 490   21046  148  20898  
Mantel Haenszel p value     <0.01  <0.01  <0.01 










Table 4.10. Smoking counts and prevalence from two data sources: Behavioral Risk 
Factor Surveillance Survey (BRFSS); Health Family Tree (HFT) 
Sex Age Smoker 












Counts Prevalence  Counts Prevalence Counts Prevalence Counts Prevalence 
Male 20-29 Yes 431 19.94  3157 16.48** 1854 14.40** 1303 20.74 
  No 1731   16005  11024  4981  
 30-39 Yes 507 20.55  7517 20.43 1505 22.61** 6012 19.95 
  No 1960   29270  5150  24120  
 40-49 Yes 414 20.68  8933 15.96** 2165 11.59** 6768 18.15** 
  No 1588   47045  16515  30530  
 50-59 Yes 225 17.97  4095 16.75 462 8.69** 3633 19.00 
  No 1027   20347  4855  15492  
 60-69 Yes 142 14.06  3287 15.99 47 8.77** 3240 16.18 
  No 868   17273  489  16784  
Female 20-29 Yes 416 15.45  2004 10.89** 1160 9.33** 844 14.16 
  No 2277   16397  11279  5118  
 30-39 Yes 509 16.30  5473 13.52** 1629 14.83** 3844 13.03** 
  No 2614   35019  9359  25660  
 40-49 Yes 377 15.44  5321 9.82** 1139 6.36** 4182 11.53** 
  No 2065   48860  16762  32093  
 50-59 Yes 222 14.07  2500 10.69** 95 3.15** 2405 11.80 
  No 1356   20888  2918  17970  
 60-69 Yes 127 9.57  2300 9.28 15 8.62 2285 9.28 
  No 1200   22497  159  22338  
Mantel Haenszel p value     <0.01  <0.01  <0.01 










Table 4.11. Exercise counts and prevalence from two data sources: Behavioral Risk 
























Male 20-29 Yes 576 42.51  2773 59.93** 2183 62.69** 590 51.53** 
  No 779   1854  1299  555  
 30-39 Yes 824 44.21  3135 44.63 622 45.90 2513 44.33 
  No 1040   3889  733  3156  
 40-49 Yes 745 38.11  5741 42.22** 2137 44.83** 3604 40.81** 
  No 1210   7858  2630  5228  
 50-59 Yes 687 35.95  2314 36.79 713 43.40** 1601 34.45 
  No 1224   3976  930  3046  
 60-69 Yes 390 28.10  1507 33.08** 35 34.31** 1472 33.05** 
  No 998   3049  57  2982  
Female 20-29 Yes 679 38.93  2457 54.32** 1931 57.28** 526 45.66** 
  No 1065   2066  1440  626  
 30-39 Yes 1033 40.93  3552 44.25** 1150 48.65** 2402 42.41 
  No 1491   4476  1214  3262  
 40-49 Yes 908 37.30  5512 41.37** 2273 48.48** 3239 37.51 
  No 1526   7812  2416  5396  
 50-59 Yes 652 27.56  1813 30.99** 398 40.95** 1415 29.01 
  No 1714   4037  574  3463  
 60-69 Yes 373 21.24  1661 29.22** 10 26.32 1651 29.24** 
  No 1383   4024  28  3996  
Mantel Haenszel p value     <0.01  <0.01  <0.01 











Table 4.12. Breast cancer counts and incidence rates from two data sources: Utah 




UCR  HFT 

















Female 20-29 Cases 58 0.04  119 0.06** 37 0.10** 82 0.06** 
  Person-
years 
1626620   1830769  377551  1438596  
 30-39 Cases 522 0.36  504 0.32** 125 0.42 379 0.29** 
  Person-
years 
1435745   1584906  295508  1289116  
 40-49 Cases 1574 1.35  964 0.93** 178 1.50 786 0.86** 
  Person-
years 
1163077   1031016  118746  912892  
 50-59 Cases 2076 2.81  945 1.51** 25 1.82** 920 1.50** 
  Person-
years 
738287   627074  13736  613333  
 60-69 Cases 2294 4.03  1084 2.74** 4 1.69** 1080 2.75** 
  Person-
years 
568905   395909  2371  393443  
Mantel Haenszel p value     <0.01  0.08  <0.01 







Table 4.13. Lung cancer counts and incidence rates from two data sources: Utah 




UCR  HFT 



















Cases 4 0.00  23 0.01** 7 0.02** 16 0.01** 
  Person-
years 
1659401   1769231  368421  1454545  
 30-
39 
Cases 28 0.02  47 0.05 11 0.04 36 0.03 
  Person-
years 
1473926   1566667  297297  1241379  
 40-
49 
Cases 122 0.10  96 0.09 18 0.11 78 0.09 
  Person-
years 
1163520   1032258  159292  866667  
 50-
59 
Cases 376 0.52  215 0.36** 10 0.35** 205 0.36** 
  Person-
years 
717142   593923  28736  566298  
 60-
69 
Cases 894 1.72  380 0.99** 4 0.90** 376 0.99** 
  Person-
years 
518444   385396  4449  380952  
Female 20-
29 
Cases 7 0.00  6 0.00 2 0.01 4 0.00 
  Person-
years 
1626620   2000000  400000  1333333  
 30-
39 
Cases 24 0.02  40 0.02 10 0.03 30 0.02 
  Person-
years 
1435745   1600000  294118  1304348  
 40-
49 
Cases 82 0.07  61 0.06 8 0.07 53 0.06 
  Person-
years 
1163077   1033898  119403  913793  
 50-
59 
Cases 270 0.37  121 0.19** 4 0.29 117 0.19** 
  Person-
years 
738287   633508  13841  622340  
 60-
69 
Cases 498 0.88  183 0.45** 1 0.42** 182 0.45** 
  Person-
years 
568905   404867  2375  402655  
Mantel Haenszel p value     <0.01  0.25  <0.01 







Table 4.14. Colon cancer counts and incidence rates from two data sources: Utah 




UCR  HFT 

















Male 20-29 Cases 15 0.01  43 0.02** 8 0.02** 35 0.02** 
  Person-
years 
1659401   1791667  380952  1400000  
 30-39 Cases 75 0.05  90 0.06 21 0.07 69 0.06 
  Person-
years 
1473926   1551724  300000  1254545  
 40-49 Cases 191 0.16  147 0.14 28 0.18 119 0.14 
  Person-
years 
1163520   1027972  158192  868613  
 50-59 Cases 439 0.61  284 0.48** 18 0.63 266 0.47** 
  Person-
years 
717142   594142  28662  565957  
 60-69 Cases 861 1.66  539 1.40** 8 1.81 531 1.40** 
  Person-
years 
518444   384177  4425  379828  
Female 20-29 Cases 13 0.01  35 0.02** 9 0.02** 26 0.02** 
  Person-
years 
1626620   1842105  375000  1444444  
 30-39 Cases 58 0.04  107 0.07** 22 0.07** 85 0.07** 
  Person-
years 
1435745   1597015  297297  1287879  
 40-49 Cases 158 0.14  156 0.15 20 0.17 136 0.15 
  Person-
years 
1163077   1033113  119048  918919  
 50-59 Cases 359 0.49  221 0.35** 13 0.94** 208 0.34** 
  Person-
years 
738287   633238  13815  619048  
 60-69 Cases 625 1.10  401 0.99** 1 0.42** 400 1.00 
  Person-
years 
568905   403421  2358  401204  
Mantel Haenszel p value     <0.01  <0.01  <0.01 




1. Enterline PE, Capt KG. A validation of information provided by household 
respondents in health surveys. Am J Public Health Nations Health. Feb 1959;49(2):205-
212. 
2. Huerta JM, Tormo MJ, Egea-Caparros JM, Ortola-Devesa JB, Navarro C. 
Accuracy of self-reported diabetes, hypertension and hyperlipidemia in the adult Spanish 
population. DINO study findings. Rev Esp Cardiol. Feb 2009;62(2):143-152. 
3. Bennett R. The Practical Guide to the Genetic Family History. New York: Wiley-
Liss; 1999. 
4. Nelson LM, Longstreth WT, Jr., Koepsell TD, van Belle G. Proxy respondents in 
epidemiologic research. Epidemiol Rev. 1990;12:71-86. 
5. Herrmann N. Retrospective information from questionnaires. I. Comparability of 
primary respondents and their next-of-kin. Am J Epidemiol. Jun 1985;121(6):937-947. 
6. Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: family history in 
risk assessment for common diseases. Ann Intern Med. Dec 15 2009;151(12):878-885. 
 
7. Williams RR, Hunt SC, Barlow GK, et al. Health family trees: a tool for finding 
and helping young family members of coronary and cancer prone pedigrees in Texas and 
Utah. Am J Public Health. Oct 1988;78(10):1283-1286. 
8. Johnson J, Giles RT, Larsen L, Ware J, Adams T, Hunt SC. Utah's Family High 
Risk Program: bridging the gap between genomics and public health. Prev Chronic Dis. 
Apr 2005;2(2):A24. 
9. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history 
definitions for defining risk of future disease. J Chronic Dis. 1986;39(10):809-821. 
10. CDC. Behavioral Risk Factor Suveillance System.  http://www.cdc.gov/brfss/. 
Accessed April 1, 2012. 
11. UDOH. Welcome to IBIS-PH: Utah's public health data resource.  http://ibis. 
health.utah.gov/. Accessed October 29, 2013. 
 
12. UDOH. Utah Healthcare Access Survey (UHAS).  http://health.utah.gov/ 
opha/OPHA_UHAS.htm. Accessed April 1, 2012. 
 
13. UCR. Utah Cancer Registry.  http://ucr.utah.edu/. Accessed April 1, 2012. 
14. ADA. Diabetes statistics.  http://www.diabetes.org/diabetes-basics/diabetes-
statistics/. Accessed October 29, 2013. 
15. SAS. About SAS.  http://www.sas.com. Accessed April 1, 2012. 
74 
 







SUCCESSFUL RISK PREDICTION FOR COMMON 
 





A person's family health history (FHH) is a valuable, noninvasive, and relatively 
inexpensive tool for predicting his or her risk of disease. Family health histories have 
aided clinicians making diagnosis and treatment decisions
1
 and have been used by public 
health professionals to identify high risk populations for disease prevention interventions, 
screening, and research.
2
  FHH has been used to independently predict the risk of many 
prevalent chronic diseases. For example, a positive FHH has been associated with 
increased risk of coronary heart disease (CHD) and myocardial infarction (MI).
3-9
 The 
association remained significant after adjusting for smoking, hypertension, high 
cholesterol, obesity, and socioeconomic status.
4-7





 and several cancers.
16-19
  
A variety of risk assessment tools based on FHH information have been 
developed,
20-29
 including My Family Health Portrait,
29
 a tool released in 2009 by the 
office of the US Surgeon General. Most of the tools are useful for collecting and 
displaying information for a clinician to review and identify potential risks. Besides 
collecting and displaying family history information, other tools also assess risks for 
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healthy individuals using rule-based logic or regression models. For example, 
MyGenerations
28
 provides cancer risk assessments, and Your Disease Risk
23
 assesses risk 
for cancer, diabetes, heart diseases, and other common diseases. In the early 1980s, a tool 
called Health Family Tree was developed at the University of Utah and was used to 
collect and use family health history and general lifestyle information to predict risks for 
chronic diseases.
22
 From 1983 to 2001, family health history and lifestyle information 
were collected from 57,238 high school students in Utah during their required high 
school health class.
31
 The information was collected by each student with help from their 
parents on a 36 x 23 inch folding paper that was designed to fit on a kitchen table. The 
information queried by the Health Family Tree about each individual can be categorized 
into three groups: demographic information, disease information, and lifestyle risk factor 
information. The collected information was then stored in a database and an algorithm 
was developed to automatically predict the risk for a variety of diseases.
31
 The risk 
prediction algorithm compared the observed number of disease events to the expected 
number of disease events within each family. The expected number of events was 
calculated by multiplying the age- and sex-specific person-years for each person in the 
family by the age- and sex- specific incidence rates generated from the entire set of 
records in the database.
31
 The large volume of persons represented in the data and the 
systematic collection of information from most high school students throughout the state 
led to the assumption that the expected rate in the general population could be derived 
from the database itself.  
The risk algorithm developed for the Health Family Tree tool was validated in 
1986 for predicting heart diseases.
31
 The researchers found that the definition of elevated 
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risk from the Health Family Tree algorithm successfully predicted unaffected family 
member’s risk of developing future CHD. The researchers also assessed the quality of the 
information reported by the student and their parents for their relatives. They selected a 
subset of the families, and contacted the family members by mailing a questionnaire with 
additional questions, phone calling, or personal interviews to confirm the reported disease 




The risk algorithm has not been validated for predicting the other diseases 
included in the family health history captured by the Health Family Tree, although 
preliminary analyses concerning MI and diabetes were reported in 2009.
32
 In addition, no 
validation has been performed to assess the impact of the lifestyle risk factors gathered by 
the tool, including smoking, drinking, overweight/obesity, and exercise. There are two 
major reasons for performing such a validation. First, the original paper-based Health 
Family Tree tool had been implemented as a web-based tool that would allow automated 
calculation of risk scores that may be presented to a user.
33
 Validation of the risk scores 
for all the diseases included in the tool is important before general use and presentation of 
risk scores to users. Second, the algorithm used by Health Family Tree could be applied 
to other family history tools that document events observed in a family; however, to 
predict future risk, the tool would need to define expected rates of disease for the 
relatives included in the family. When a tool has no historic data that can be used to 
generate expected rates, the system would need to use reference rates in the risk 
algorithm and understand their impact on risk prediction if the rates are likely to under- 
or overestimate the true population rates.  
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Therefore, the objectives of this research were: 1) to describe the absolute rates 
generated from the Health Family Tree database and used in the risk prediction; 2) to 
validate the Health Family Tree risk algorithm by assessing the risk score's ability to 
predict an individual's future risk for selected common diseases; and 3) to validate the  







From 1983 to 2001, a total of 1,195,599 records were generated and stored in the 
Health Family Tree database. The records included individuals’ self- or proxy- reported 
medical history and may have duplicates if more than one student from a single family 
participated in the class assignment. However, we do not expect this duplication will 
impact the expected rates used in the risk prediction algorithm because the algorithm 
predicts risks based on relative risk, which compares observed events with expected 
events. When duplication exists, both observed and expected events will be duplicated 
and the ratio will remain the same. Also, we do not expect that persons at higher risk for 
any disease included in the analysis will be disproportionately represented by families 
with more than one child participating in the Health Family Tree class exercise.  
We systematically checked all variables in the database of 1,195,599 records for 
errors and missing values. After cleaning the “illegal” data, 1,021,909 (85.5%) “valid” 
records remained. We defined and handled errors and missing values in the following 
manner:  
 When “age” was missing for “living” relatives, we calculated age using the 
reported year of birth.  
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 When there was a mismatch between the reported “sex” of the family member 
and the type of relative (i.e., grandmother should be a female), we used the 
relationship defined on the Health Family Tree (i.e., used the “relative 
number”) to assign a value for “sex.” For example, relative number 4 and 
number 6 are grandmothers of the high school student and their “sex” should 
be “female,” and never “male.”  
 Records with more than four reasons of death were removed from the analysis 
assuming that they were errors. 
 Records for parents of a high school student that report an age less than 25 
years were removed from the analysis. 
 Records with an invalid or uncorrectable “sex,” “age,” “relative number,” or 
“year of birth” were removed from the analysis. 
For each student, we treated their paternal and maternal family as separate 
families (Figure 5.1): one family includes the student, siblings, mother, maternal aunts 
and uncles, and maternal grandparents; a second family includes the student, siblings,  
father, paternal aunts and uncles, and paternal grandparents. 
 
 
Generate rates from the Health Family Tree 
 
To calculate the rates of diseases and lifestyle risk factors, we used all individuals 
between 20 and 99 years of age in the Health Family Tree database at the time of data 
collection. Incidence rates stratified by sex and age groups in 10-year-increments were 
calculated for all diseases collected in the tool (diabetes, MI, CHD, stroke, high blood 
pressure, high blood cholesterol, breast cancer, lung cancer, and colon cancer), while 
prevalence rates were calculated for all risk factors collected in the tool (smoking,  
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drinking, overweight/obesity, and exercise). 
 
 
Calculate risk score 
 
As described in the previous publication from 1986,
31
 the FHS is calculated using 
the following equation: 
If | O – E | > ½ then,    
Or,  
if | O - E | ≤ ½ then  FHS = 0 
The observed incidence of disease (O) was the observed number of events in the family; 
the expected number of events (E) was calculated by multiplying the age- and sex-
specific person-years for each person in the family by the age- and sex- specific incidence 
rates generated from all records in the database.
31
 
After calculating the risk score, the individuals were classified into the following 
groups based on the risk scores calculated by the algorithm: 
 Very high risk group:  (FHS ≥ 2.0)  
 High risk group:  (1.0 ≤ FHS < 2.0)  
 Medium risk group:  (0.5 ≤ FHS < 1.0) 
 Low risk/Reference group: (FHS < 0.5) 
 
 
Validate risk algorithm 
 
The validation of the risk algorithm was performed for each disease and health 
condition collected. A retrospective cohort study design was used. From the cleaned 
original database, we created two datasets for analysis: a “baseline dataset” and a 
“follow-up dataset.” The “baseline dataset” was based on the family members’ statuses as 
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of a “cut-off” year, defined as 13 years prior to the year of data collection. This definition 
was used in the previous validation study in 1986 to balance the number of events in a 
family prior to and after the cut-off years.
31
 The prior study also found that different cut-
off years had little impact on the follow-up incidence rates.
31
 The “baseline dataset” 
contained each individual's disease and vital status as of the cut-off year and was then 
used by the family history score (FHS) algorithm to calculate the risk. The “follow-up 
dataset” contained the disease events that occurred after the cut-off date and served to 
document outcomes. The calculated risk scores were merged with the outcomes in the 
“follow-up dataset” and then assessed using regression analysis. (Figure 5.2) 
We analyzed the differences between the reference group and the very high, high, 
and medium risk groups using a Cox proportional hazards model. Follow-up time was 
defined as the time since the cut-off year until the onset of the condition (incidence), 
death, or the year of data collection, whichever was earliest. For every health condition, 
age was always included in the Cox proportional hazards model as a covariate. We 
grouped the individual’s age at the cut-off year into five groups (20-39, 40-49, 50-59, 60-
69, and 70-89), and used the age group as a covariate. To test the effect of behavioral risk 
factors including smoking, drinking, weight, and exercise, the model was evaluated 
twice: with and without risk factors as covariates. Before including lifestyle risk factors 
as covariates, interaction analysis was performed to examine the interaction effect 
between family disease history and each of the risk factors. Then the risk factors were 
added in the model all at once to test the effect of risk factors. 
All the analyses were performed using SAS version 9.2.
34
 A p-value < 0.05 was 
considered statistically significant. We obtained approval from the Institutional Review  
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Board at the University of Utah for this analysis. 
 
 
Validate risk algorithm using public rates 
 
To test the ability of the algorithm to predict future onset of disease using publicly 
available data, we used several different data sources and estimated age- and sex-specific 
“expected” rates from the available data. We excluded CHD, high blood pressure, and 
high blood cholesterol from this analysis because no public incidence rates were 
identified.   
First, in order to assess prediction of future diabetes, we used the estimated 
national incidence of being diagnosed with diabetes in the year 1999 from the National 
Health Interview Survey of the National Center for Health Statistics (NCHS).
35
 The 
NCHS data only provided estimated diabetes incidence rates for three age groups (18-44 
years, 45-64 years, and 65-79 years), while the Health Family Tree algorithm used 
incidence rates for age groups ranging from 20 to 99 in 10 year increments (i.e., 20-29 
years, 30-39 years, etc., up to 90-99 years). To estimate the incidence rates for the age 
groups used by the algorithm, we used piecewise linear interpolation for the age groups 
ranging from 20 to 79 years. We applied the incidence rate for the 70-79 age group to the 
80-89 and 90-99 age groups. Second, to generate ‘expected’ rates of MI and stroke, we 
used incidence rates reported for the U.S. from the Atherosclerosis Risk in Communities 
Surveillance reported by the American Heart Association
36
 and again performed 
piecewise linear interpolation to generate estimated rates for each age- and sex-specific 
subgroups. Third, to obtain incidence rates for breast, lung, and colon cancer, we queried 
the Utah Cancer Registration (UCR)
37
 using the  SEER*Stat
38
 tool. Cancer rates in the 
UCR are available for every age ranging from 0 to 84 years old, and one rate is reported 
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for anyone 85 years and older. Again, we applied the rates for the age group 70-79 years 
to the age groups 80-89 and 90-99 years. Finally, we obtained the expected prevalence 
rates of smoking and exercise from the Behavioral Risk Factor Surveillance System 
(BRFSS)
39




Using the expected rates from the public data sources and the risk algorithm 
previously described, we calculated risk scores for diabetes, MI, stroke, breast cancer, 
lung cancer, and colon cancer. Then, we validated the risk algorithm using the same 
process described above. Finally, we compared the risk scores calculated using public 
data sources as reference with the scores calculated using Health Family Tree as 
reference. We used the Finn's r statistics to measure concordance between the two 
references. We also used Bowker's test of symmetry to analyze the direction of 
differences when there were disagreements in the risk categories assigned when using the  







There were 1,021,909 records included in the analysis, which came from a total of 
71,127 family units (each student's paternal and maternal family was treated as a separate 
family unit). After using the cut-off year to split the original database, 1,006,566 records 
were included in the “baseline” dataset and used to calculate risk scores, and from 
956,169 to 981,418 records were included in the “follow-up” datasets and used to assess 
outcomes. The numbers varied by disease type because only those remaining “at risk” for 
that disease type were included in the “follow-up” dataset.  
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Rates from the Health Family Tree 
The rates for disease and risk factors varied by sex and age group (Table 5.1). For 
all diseases, the incidence of disease increased with age. In general, males (especially 
males in older age groups) had higher incidence rates of CHD, MI, stroke, lung cancer, 
and colon cancer than females at the same age. However, females 60-69 years of age had 
higher incidence rates of high blood pressure than males. Sex differences in incidence are 
not observed for diabetes and high blood cholesterol. For risk factors, males had higher 
prevalence rates than females except for the category of overweight/obese. The rates of 




Validation of risk algorithm 
 
Any elevated risk score (very high, high, or medium), with or without 
consideration for lifestyle risk factors of smoking, drinking, overweight/obesity, or lack 
of exercise, was predictive for future onset of diabetes, high blood pressure, and high 
blood cholesterol (all Cox proportional hazards model p < 0.0001). Similarly, very high 
risk scores (FHS ≥ 2.0) were predictive for all diseases included in the analysis, with or 
without considering the lifestyle risk factors (Cox proportional hazards model p < 0.0001 
or p = 0.0002). The other risk scores (high and medium) were usually, but not always, 
predictive for the diseases analyzed (Table 5.2). When assessing risk factors (smoking, 
drinking, overweight/obesity, and exercise), we found no significant interaction between 
family disease history and each risk factor. So all lifestyle risk factors themselves were 
added as covariates one at a time in the hazards model, and the significance of family 
history was evaluated after every addition of a risk factor. The inclusion of any lifestyle 
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risk factors in the models for most diseases did not change the predictive ability of the 
family history risk scores reported without consideration of the lifestyle risk factors. Only 
the prediction of lung cancer was affected by adding lifestyle risk factors. When the risk 
factor of smoking was added to the hazard model, the family history risk score was no 
longer able to predict future onset of lung cancer for those families classified at high risk  
(1≤ FHS < 2) for both males and females. 
 
 
Validation of risk algorithm using public data 
 
The predictive ability of risk scores using the rates from public data sources for  
expected rates (Table 5.3) were similar to the findings based on rates generated from the 
Health Family Tree database (Table 5.2). Only two subgroups showed a change in the 
statistical significance of the hazard ratio. The hazard ratio for females classified at high 
risk score for stroke became predictive using the public data. In contrast, the hazard ratio 
for males classified as high risk for lung cancer became not significant (p = 0.3580 for 
males; p = 0.1719 for females). Similarly, including both risk factor rates (smoking and 
exercise) queried from public data as covariates in the model did not change the 
significance level of the risk prediction for most diseases except for those in the high risk 
group for lung cancer.  
When comparing risk scores calculated using the Health Family Tree population 
as a reference to generate expected rates with risk scores calculated using rates from 
public data sources, most risk assessment groups remained the same (Table 5.4-5.9). The 
proportion of individuals classified into the same risk groups using both reference 
populations is: diabetes 94.2%, MI 94.5%, stroke 97.6%, breast cancer 99.6%, lung 
cancer 99.9%, colon cancer 99.9% (Finn's r statistics = 0.9). The agreement was mostly 
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due to the fact that most individuals are at low risk for any of the above diseases. 
Bowker's test of symmetry (p < 0.001 for each disease) indicated that the risk scores 
calculated using the Health Family Tree as reference were disproportionately in one 
direction when they did not agree with the scores defined using the public source as 
reference. When the risk scores calculated from the two references were not in the same 
group (Table 5.4-5.9), more people were classified into the higher risk group when using 






Our validation study of the Health Family Tree risk algorithm indicated that the 
very high risk scores (FHS ≥ 2.0) derived from the algorithm can effectively predict the 
risks for all the concerned diseases and conditions for an adult population who is between 
20 and 99 years of age. We also confirmed the predictability of the FHH after including 
lifestyle risk factors as covariates in the risk model. In addition, we demonstrated that the 
Health Family Tree risk algorithm could be applied to other systems that collect and store 
family history information. Risks can be predicted by comparing observed events 
collected by the system with expected events that may be calculated using disease rates 
from public data sources as expected rates.  
We described the absolute rates (i.e., incidence for diseases and prevalence for 
lifestyle risk factors) generated from the Health Family Tree database and used in the risk 
prediction algorithm. In a separate previous analysis, the absolute rates were shown to 
have an age- and sex-specific pattern that is similar to public rates although many of the 
rates underestimated incidence and prevalence reported in public data sources. These 
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rates were obtained from authoritative public data sources such as the Utah Department 
of Health and the Utah Cancer Registry. 
The family history risk algorithm validation demonstrated that when the risk score 
is high enough, all concerned diseases could be predicted based on merely the history 
reported by one or a few family members. For a subset of the diseases including diabetes, 
high blood pressure, and high blood cholesterol, any elevated risk scores predict the 
individual's risk for developing these diseases. When a single patient or a population that 
is not affected but categorized into one of the risk level (very high, high, or medium) 
groups for a specific disease, clinical and public health decision makers may choose an 
appropriate preventative strategy for this person or population based on their risk level.  
Additionally, we applied publically available disease rates to validate the risk 
algorithm. This established the process to generalize the risk algorithm to other systems 
that collect FHH. A prerequisite to adopt the Health Family Tree algorithm is to generate 
the expected rates from a reference population. If the other system contains a large 
number of records representing the general population with similar information collected 
by the Health Family Tree, the same method of generating expected rates and the risk 
algorithm could be applied directly. However, if the other system does not collect enough 
records and information to generate expected population-based rates, the population 
incidence rates recorded in public data sources can be used as a reference to calculate the 
expected events for the algorithm. Then the predicted risks can be used for clinical or 
public health decision support, such as identifying high risk individuals and/or 
populations for further screening.  
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When making decisions based on this risk prediction, clinicians and public health 
professionals should be aware that the choice of reference rates will impact risk 
prediction by affecting the expected number of events. If a population with a lower than 
expected incidence of chronic disease is chosen as the reference to predict risks using this 
algorithm, the prediction scores will be higher than when using the expected risk 
population as reference. On the other hand, if a higher risk population serves as the 
reference, then the prediction scores will be lower than when using an average (i.e., 
expected) risk population as reference. These effects should be considered when 
researchers, clinicians, and public health professionals are making decisions based on the 
risk prediction generated from a referent population.  
This study has many strengths. While many other risk prediction methods simply 
use the counts of affected relatives and the degree of relationships to estimate the risk, we 
used a quantitative risk score. To calculate the quantitative risk score, information about 
first-degree relatives of the student's parents was needed. Besides the student, the parents 
were also informants as they were actively involved in the data collection process. 
Furthermore, calculation of the risk score takes advantage of information about the 
family size, age of persons in the family, and the incidence of disease in the family and 
the reference population. The reference population could be either the population of the 
family history database itself or the general public population. The information included 
in this calculation is more comprehensive than the information often used to assess 
family history of common disease (e.g., the numbers of affected first or second degree 
relatives). Finally, using discrete cut-off risk score categories in the prediction instead of 
continuous risk scores is practical: the unaffected population will be categorized into 
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different risk levels after risk assessment, and high risk groups can be targeted for 
different screening and follow-up strategies. 
The possible barriers associated with extensive use of FHH are lack of awareness 
of the importance of FHH, lack of time, lack of accurate, detailed information, and lack 
of validated risk assessment.
1,2,20,41,42
 This study mainly addressed the challenge of lack 
of validated risk assessment. First, this study described the disease rates used in the 
Health Family Tree risk algorithm. Then the algorithm was validated by examining the 
relationship between the predicted relative risk (risk scores based on FHH prior to a 
certain year) and the reported outcome (the health events that occurred after a certain 
year). By substituting some disease and risk factor rates generated from the database with 
publically available data rates, this study confirmed the feasibility of adopting the Health 
Family Tree algorithm in other systems that collect family history information.  
This study has limitations. First, the data collected by the Health Family Tree 
were either self-reported or proxy-reported, which may lead to recall bias. In a separate 
study, we assessed data quality by comparing the data reported by our participants with 
data collected and recorded by authoritative data sources, such as standardized public 
health surveys and the cancer registry. That analysis found most diseases were 
underreported in the Health Family Tree database when compared to authoritative data 
sources. When the reference population used in the analysis is underreporting the 
diseases incidence, the risk score became inflated. Inflated scores will increase the 
sensitivity and decrease the specificity of the risk prediction. In the context of using the 
risk scores for public health screening and recommending healthy behaviors, higher 
sensitivity with lower specificity is potentially acceptable. Another limitation concerns 
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generalizability. The study population was primarily from Utah, which has one of the 
highest proportions of white residents compared to many other states. Also, family sizes 
in Utah are larger than those in many other states. In addition, the levels of tobacco and 
alcohol use are lower. For example, in 2011, the percentage of adults aged 18 and older 
who reported current cigarette smoking was 11.3% for Utah,  but 20.4% for US;
43
 the 
percentage of adults who reported binge drinking in the past 30 days was 12.0% for Utah, 
but 18.3% for US.
44
 However, a previous Texas study showed similar results when 
comparing their data from the HFT project with Utah.
45
 Furthermore, the risk prediction 
is based on relative risk that compares observed with the expected incidence calculated 
from a reference population. As long as the appropriate reference population is selected, 
the risk score is valid. Despite the limitations, we recommend use of the Health Family 
Tree risk algorithm when family history data is available in order to identify persons in 
need of further assessment for risk. This strategy is a potentially low cost method for 
subsetting a population and finding those at high risk. 
In conclusion, the Health Family Tree risk algorithm can effectively predict a 
healthy adult individual's future risk for developing a variety of common chronic diseases 
by using the individual's family health history, with or without considering lifestyle risk 
factors. Other family health history tools could use the Health Family Tree risk algorithm 
with the family health history data collected in their system and incidence data derived 






















Figure 5.1. Family unit structure and number of records in the Health Family 
Tree. Student's paternal and maternal families were treated as separate family 
units: one family unit (within the dashed outline) includes the student, siblings, 
mother, maternal aunts and uncles, and grandparents; a second family unit (within 
the dashed-and-dotted outline) includes the student, siblings, father, paternal aunts 



















Maternal aunts & uncles 
229,693 (22.48%) 
 































Figure 5.2. Retrospective cohort study design illustration. The figure represents 
one "family" used for analysis -the student's maternal side of the family. Diabetes 
events that happened during the "baseline" period before the cut-off year (1980 in 
this family’s case) were used to calculate risk. Events that happened during the 
"follow-up" period after the cut-off were used to validate the prediction. 
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Table 5.1. Incidence rates of chronic diseases and prevalence rates of lifestyle risk 
factors extracted from the Health Family Tree, stratified by sex and age, reported 
1983-2001 
 Age groups 
20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99 
Incidence rates for diseases  
Diabetes (‰) 
Male 0.22 0.53 1.41 2.74 5.58 8.69 9.47 6.46 
Female 0.27 0.69 1.47 2.84 5.71 8.86 11.54 7.17 
Myocardial infarction (‰) 
Male 0.08 0.51 2.39 6.76 13.54 22.22 29.92 27.53 
Female 0.05 0.20 0.64 1.90 4.87 10.16 17.70 17.37 
Coronary heart diseases (‰) 
Male 0.09 0.52 2.48 7.06 14.80 25.82 34.44 29.94 
Female 0.06 0.22 0.70 2.03 5.33 11.62 19.67 18.42 
Stroke (‰) 
Male 0.03 0.11 0.43 1.42 4.30 11.23 23.37 27.10 
Female 0.05 0.15 0.40 1.12 3.13 9.36 20.70 31.62 
High blood pressure (‰) 
Male 0.63 2.65 6.45 9.13 14.92 19.54 21.71 16.74 
Female 0.56 2.22 5.38 9.63 17.90 27.72 36.62 34.67 
High blood cholesterol (‰) 
Male 0.29 1.62 4.26 5.22 8.34 10.21 9.36 5.38 
Female 0.22 1.16 2.69 4.07 8.24 11.03 10.70 6.18 
Breast cancer (‰) 
Male N/A N/A N/A N/A N/A N/A N/A N/A 
Female 0.07 0.37 1.03 1.55 2.64 3.96 5.63 3.74 
Lung  cancer (‰) 
Male 0.02 0.06 0.21 0.69 1.53 2.14 2.38 1.26 
Female 0.01 0.05 0.13 0.32 0.62 0.74 0.97 1.65 
Colon cancer (‰) 
Male 0.02 0.07 0.19 0.59 1.43 2.72 4.24 5.28 
Female 0.03 0.09 0.20 0.46 1.10 1.88 2.66 2.34 
Prevalence rates for lifestyle risk factors 
Smoking (%) 
Male 18.51 22.72 18.68 20.92 20.02 12.74 8.34 5.77 
Female 12.16 14.62 11.11 12.08 10.22 4.97 2.20 2.12 
Overweight/obese (%) 
Male 2.32 4.62 6.69 7.71 7.87 6.25 3.84 3.45 
Female 4.12 7.96 9.77 11.70 11.64 9.61 6.93 4.63 
Drinking (%) 
Male 35.00 40.41 34.57 34.67 36.65 28.70 22.20 18.58 
Female 27.36 31.81 26.28 24.92 24.09 16.57 11.21 9.26 
Exercise  (%) 
Male 64.69 55.73 50.65 46.28 41.18 39.69 37.41 42.33 







Table 5.2. Hazard ratios and p-values of the Cox proportional hazards model, by 
gender and family history score category, with age as a covariate 
 Very high (FHS≥2) High (1≤FHS<2) Medium (0.5≤FHS<1) 
 Male Female Male Female Male Female 
Diabetes       
Hazard ratio 3.6 3.4 2.1 2.0 2.0 1.8 
95% CI (3.2,4.1) (3.0,3.8) (1.9,2.3) (1.8,2.1) (1.8,2.2) (1.6,2.0) 
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Myocardial infarction 
Hazard ratio 2.4 1.7 1.7 1.4 1.6 1.1 
95% CI (2.1,2.7) (1.4,2.0) (1.6,1.9) (1.2,1.5) (1.4,1.7) (0.9,1.3) 
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.2632 
Coronary heart diseases 
Hazard ratio 2.3 1.7 1.6 1.2 1.6 1.1 
95% CI (2.0,2.5) (1.4,2.0) (1.5,1.8) (1.1,1.4) (1.4,1.7) (1.0,1.3) 
p value <0.0001 <0.0001 <0.0001 0.0002 <0.0001 0.0735 
Stroke       
Hazard ratio 1.5 1.7 0.9 1.1 0.7 1.0 
95% CI (1.2,2.0) (1.4,2.1) (0.7,1.2) (0.9,1.3) (0.5,1.0) (0.8,1.3) 
p value 0.0014 <0.0001 0.6651 0.5647 0.4465 0.9748 
High blood pressure 
Hazard ratio 3.1 2.9 2.2 2.2 1.8 1.7 
95% CI (2.9,3.3) (2.7,3.1) (2.1,2.4) (2.0,2.3) (1.7,1.9) (1.6,1.8) 
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
High blood cholesterol 
Hazard ratio 4.8 4.6 3.1 2.4 2.6 2.3 
95% CI (4.5,5.2) (4.2,5.0) (2.9,3.3) (2.2,2.6) (2.5,2.8) (2.2,2.5) 
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Breast cancer 
Hazard ratio N/A 2.6 N/A 1.7 N/A 0.8 
95% CI N/A (2.2,3.1) N/A (1.2,2.2) N/A (0.3,2.2) 
p value N/A <0.0001 N/A 0.0009 N/A 0.6818 
Lung cancer       
Hazard ratio 5.2 4.6 3.4 3.6 0.0 0.0 
95% CI (3.7,7.5) (3.1,6.8) (1.3,9.0) (1.2,11.2) (0.0,0.0) (0.0,0.0) 
p value <0.0001 <0.0001 0.0149 0.0274 0.9516 0.9667 
Colon cancer       
Hazard ratio 2.0 2.7 1.3 1.7 0.0 0.0 
95% CI (1.4,2.9) (2.0,3.7) (0.6,2.8) (0.8,3.4) (0.0,0.0) (0.0,0.0) 









Table 5.3. Hazard ratios and p-values of the Cox proportional hazards model, using 
public rates as reference in the algorithm, with age as a covariate, without risk 
factors 
 Very high (FHS≥2) High (1≤FHS<2) Medium (0.5≤FHS<1) 
 Male Female Male Female Male Female 
Diabetes       
Hazard ratio 5.1 5.2 3.4 3.2 2.2 2.1 
95% CI (4.1,6.4)) (4.1,6.4) (2.8,4.0) (2.7,3.8) (1.9,2.5) (1.8,2.4) 
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Myocardial infarction 
Hazard ratio 2.1 1.5 1.6 1.3 1.5 1.0 
95% CI (1.9,2.3) (1.3,1.8) (1.4,1.7) (1.2,1.4) (1.4,1.7) (0.8,1.1) 
p value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 0.7115 
Stroke       
Hazard ratio 1.7 1.5 1.2 1.6 0.9 0.9 
95% CI (1.2,2.4) (1.1,2.2) (0.9,1.6) (1.3,2.0) (0.6,1.2) (0.7,1.2) 
p value 0.0037 <0.0001 0.2750 <0.0001 0.4300 0.4450 
Breast cancer 
Hazard ratio N/A 2.7 N/A 1.8 N/A 1.4 
95% CI N/A (2.2,3.3) N/A (1.3,2.3) N/A (0.8,2.4) 
p value N/A <0.0001 N/A <0.0001 N/A 0.2238 
Lung cancer       
Hazard ratio 5.5 4.7 1.9 2.6 0.0 0.0 
95% CI (3.8,7.7) (3.2,6.9) (0.5,7.7) (0.7,10.5) (0.0,0.0) (0.0,0.0) 
p value <0.0001 <0.0001 0.3580 0.1719 0.9518 0.9669 
Colon cancer       
Hazard ratio 2.0 2.6 1.3 1.8 0.0 0.0 
95% CI (1.4,2.8) (1.9,3.6) (0.6,2.8) (0.9,3.6) (0.0,0.0) (0.0,0.0) 




Table 5.4. Comparison of family history scores (FHS) for diabetes generated by the 
Health Family Tree (HFT) algorithm based on two references  
Percentages (%) Rates from public source* 




















FHS<0.5 94.0 0 0 0 94.0 
0.5≤FHS<1 2.5 0 0 0 2.5 
1≤FHS<2 1.8 0.6 0 0 2.4 
FHS>2 0 0.4 0.5 0.2 1.1 
Total 98.3 1.0 0.5 0.2 100 
*Public source: incidence of diagnosed diabetes published by Centers for Disease Control and 
Prevention, available at: http://www.cdc.gov/diabetes/statistics/incidence/fig5.htm 
 
Table 5.5. Comparison of family history scores (FHS) for myocardial infarction 
generated by the Health Family Tree (HFT) algorithm based on two references  
Percentages (%) Rates from public source* 




















FHS<0.5 89.2 0 0 0 89.2 
0.5≤FHS<1 2.5 1.3 0 0 3.8 
1≤FHS<2 0 2.1 2.3 0.9 5.3 
FHS>2 0 0 0 1.7 1.7 
Total 91.7 3.4 2.3 2.6 100 





Table 5.6. Comparison of family history scores (FHS) for stroke generated by the 
Health Family Tree (HFT) algorithm based on two references 
Percentages (%) Rates from public source* 




















FHS<0.5 96.1 0 0 0 96.1 
0.5≤FHS<1 0.9 0.3 0 0 1.2 
1≤FHS<2 0.1 0.9 0.6 0 1.6 
FHS>2 0.2 0 0.4 0.6 1.2 
Total 97.3 1.2 1.0 0.6 100 




Table 5.7. Comparison of family history scores (FHS) for breast cancer generated by 
the Health Family Tree (HFT) algorithm based on two references  
Percentages (%) Rates from public source* 




















FHS<0.5 97.6 0 0 0 97.6 
0.5≤FHS<1 0.1 0.2 0 0 0.3 
1≤FHS<2 0 0.2 0.6 0 0.8 
FHS>2 0 0 0.2 1.2 1.4 
Total 97.7 0.4 0.8 1.2 100 
*Public source: Utah Cancer registry, queried through SEER*Stat tool 
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Table 5.8. Comparison of family history scores (FHS) for lung cancer generated by 
the Health Family Tree (HFT) algorithm based on two references 
Percentages (%) Rates from public source* 




















FHS<0.5 98.5 0 0 0 98.5 
0.5≤FHS<1 0 0.1 0 0 0.1 
1≤FHS<2 0 0 0.3 0.1 0.4 
FHS>2 0 0 0 1.0 1.0 
Total 98.5 0.1 0.3 1.1 100 
*Public source: Utah Cancer registry, queried through SEER*Stat tool 
 
Table 5.9. Comparison of family history scores (FHS) for colon cancer generated by 
the Health Family Tree (HFT) algorithm based on two references 
Percentages (%) Rates from public source* 




















FHS<0.5 98.2 0 0 0 98.2 
0.5≤FHS<1 0 0.2 0 0 0.2 
1≤FHS<2 0 0 0.5 0.1 0.6 
FHS>2 0 0 0 1.0 1.0 
Total 98.2 0.2 0.5 1.1 100 
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DEVELOPING NEW MODELS TO PREDICT DIABETES  
 
BY APPLYING MACHINE LEARNING METHODS 
 





Diabetes mellitus is a serious and very costly public health problem in the United 
States. According to data released in 2011 by Centers for Disease Control and 
Prevention, 25.8 million U.S. children and adults, 8.3% of the population, have diabetes.
1
 
In 2012, total health care costs of diagnosed diabetes in the United States were $245 
billion, which was a 41% increase compared to 2007.
2
 In 2007, diabetes was listed as the 
underlying cause or contributing factor for a total of 231,404 deaths.
1
 Meanwhile, the 
incidence of diabetes continues to grow. The number of diagnosed diabetes cases is 
projected to reach 29 million by 2050.
3
  
Numerous research methods including data mining and machine learning have 
been applied to diagnose or predict the development of diabetes. Data mining is the 
extraction of implicit, previously unknown, and potentially useful information from data.
4
 
Machine learning is the technical basis of data mining and was defined as the acquisition 
of structural descriptions from examples.
4
 Besides their application in industrial fields 
such as retail and banking, data mining and machine learning techniques have been 
applied to healthcare data and research.
5,6
 Various machine learning methods such as 
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Decision Trees, Naive Bayes/Bayesian Networks, and Support Vector Machine (SVM) 
have been applied to healthcare databases for diagnosis or prediction of the development 
of diabetes,
7-10
 coronary heart diseases,
11,12
 and other diseases.
13-16
  
When compared to traditional statistical methods, machine learning methods have 
some advantages. For example, when predicting the development of diabetes, we treat the 
disease outcome (having diabetes or not) as the dependent variable, and a series of factors 
such as sex, age, weight, diet, and family health history of diabetes as independent 
variables. Traditional statistical methods assume the following a priori data model 
between the independent and dependent variables: response variable = f (predictor 
variable, random noise, parameters).
17
 The assumed data model may not be true. In 
contrast, machine learning methods rely on the input and output data themselves rather 
than an assumed a priori data model. Machine learning methods allow a black box 
between independent and dependent data and aim to find models that predict outcomes 
(such as diagnosis of diabetes) based on inputs (various features present in the data). The 
approach is to find a function f(x)—an algorithm that operates on x to predict the 
responses y. These methods focus on the data themselves and the properties of 
algorithms, and their use has advanced rapidly in recent decades.
17
 
Besides the theoretical advantages, machine learning methods may have 
additional practical benefits for the research questions addressed in this dissertation. The 
Health Family Tree algorithm introduced in previous chapters used traditional statistical 
methods to predict a healthy individual's risk for developing selected diseases. To 
implement this statistical model, the method requires a reference population to generate 
the expected incidence rates. In previous studies, we used the Health Family Tree 
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population (>1 million health records reported by the informants) to generate the 
incidence rates to calculate a family history risk score. For other systems that collect 
family health history (FHH) information without a large representative population to use 
the same algorithm, we also queried available public disease incidence rates and used 
interpolation methods to estimate the incidence rates that were needed by the algorithm. 
With the exception of cancer, very limited information about incidence rates is available 
for most chronic diseases. For many chronic diseases, the onset of the disease is not clear, 
so public health standardized surveys often query participants about their chronic disease 
status to generate prevalence rates.  Public health surveys often do not ascertain an onset 
date, which is required for calculating incidence rates. Thus, the incidence rates of most 
chronic diseases are not available in public data sources. As a result, without 
interpolating incidence rates from prevalence data, the  Health Family Tree algorithm 
may be difficult to implement in other systems.  On the other hand, machine learning 
techniques build predictive models by training on the features collected by the system. 
Ideally, these trained and validated models can be applied to predict diabetes risk in other 
systems that collect these same features. Though there are many advantages of machine 
learning methods, there are disadvantages. In general, machine learning requires a large 
number of samples to train the classifiers. In addition, the algorithms used by machine 
learning methods may be very complicated and be a black box to the user.
17
 For our 
purposes, we have a large data set with which to train the algorithms, and we are most 
interested in accurate prediction; therefore, these limitations may not apply to our 
research.   
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There are two key types of machine learning methods: supervised and 
unsupervised. Supervised machine learning operates under supervision by being provided 
with the actual outcome for each training example.
4
 In contrast, unsupervised machine 
learning tries to find hidden structure in unlabeled data without knowing the outcomes.
4
 
The goal of this study was to develop models to predict the presence or risk of diabetes 
using supervised machine learning methods in order to identify high and low risk 
populations for population-based studies or public health screening.  The specific 
objectives were to use the limited set of information about a subject (i.e., age and sex, 
comorbidities, lifestyle risk factors, and family health history) available in the Health 
Family Tree database and three different data mining algorithms to: a) predict the 
presence of diabetes among individuals in the sample, and b) predict the future  







The target population included the students’ parents, aunts and uncles (n = 
578,062 individuals) in the Health Family Tree database. This sample was drawn from 
the set of validated records used in Chapters 4 and 5. Considering there is no parental 
information for the students’ grandparents, and the low incidence of diabetes in the 
students and their siblings, we chose the students’ parents, aunts, and uncles as the study 
population for this analysis. 
The target disease for this analysis was diabetes. Literature shows that the risk 
factors for diabetes include age, sex, weight/Body Mass Index (BMI), heart disease, 
stroke, family history of diabetes among first-degree relatives (parents and siblings), 
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smoking, and lack of physical activity.
18,19
 The American Diabetes Association 
recommended a set of risk factors including but not limited to: body mass index, physical 
inactivity, first-degree relative with diabetes, race, hypertension, HDL cholesterol level, 
obesity, and history of cardiovascular diseases.
20
 Multiple diabetes risk score tools such 
as the Cambridge diabetes risk score,
21
 Danish diabetes risk score,
22
 and Indian diabetes  
risk score
23
 use a similar set of risk factors for their risk calculation.  
 
 
Data preparation and feature examination 
 
Supervised machine learning (whereby a desired target output is defined) was 
used to discover patterns in the Health Family Tree database and build models for 
classifying an individual’s risk for developing diabetes. The outcome of interest was a 
binary classification: the individual is classified as having diabetes or not. The features 
shown in Table 6.1 were all included in the machine learning process because they either: 
1) were collected by the Health Family Tree and are risk factors described in the 
literature and guidelines; or 2) were family health history related features that were 
generated from collected data on first-degree relatives and showed significant results 
(95% CI of odds ratio did not include one) from the univariate analysis.  
The following procedures were conducted before training the classifiers:  
 Feature preparation: five family history related features were created in the SAS 
database including: if the individual has a diabetic mother, if the individual has a 
diabetic father, if the individual has a diabetic sibling, the number of first-degree 
relatives with diabetes, and the ratio of first-degree relatives with diabetes to all 
first-degree relatives. When creating the family history related features, only 
events that happened before the subject's onset of diabetes were counted in the 
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family health history. Similarly, when classifying the subject’s comorbidities, we 
only included comorbidities that were present when the subject developed 
diabetes. We made this assessment by comparing the year of onset for the diabetes 
and the other diseases reported by the subject.  
 Feature selection: Given the limited set of 20 features available in the Health 
Family Tree database relative to the large number of instances (~578,000), no 
further feature selection was required.  There were 14 features directly available  





Three classifiers including logistic regression, Bayesian network, and support 
vector machine (SVM) (see Table 6.2) were chosen to test prediction accuracy. The 
algorithms were selected for the following reasons:  
a) The outcome is known in the Health Family Tree database; therefore the problem 
requires supervised machine learning methods. The selected algorithms all use 
supervised learning methods. Algorithms that use unsupervised machine learning 
such as clustering were excluded;  
b) The outcome requires a binary classification, i.e., it predicts the disease or risk 
status as "yes" or "no." The selected algorithms can provide a binary output; and  
c) The dataset contains a large number of instances (578,062 subjects: parents and 
uncles and aunts), and the choice of classifier has less effect on the machine 
learning results. In theory, all classifiers should give similar results. 
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Classifier training and evaluation 
Waikato Environment for Knowledge Analysis (WEKA)
24
 version 3.7.9 was used 
to train and evaluate the models. Ten-fold cross validation was used to evaluate the 
trained models. 
The three classifiers were evaluated and the following performance metrics were 
compared: recall (i.e., sensitivity), precision (i.e., positive predictive value), and F-
measure. The F-measure is calculated based on recall and precision. 
Recall = TP/(TP + FN)  
Precision = TP/(TP + FP) 
F-measure = 2 * precision * recall/(precision + recall) 
where TP, FP, TN, and FN represent the number of true positives, false positives, true 
negatives, and false negatives, respectively (Table 6.3). 
The prevalence of positive diabetic individuals in the HFT database was relatively 
low (2.5%). This type of imbalanced dataset can affect the performance of various 
classifiers.
25
 Therefore, we used the undersampling technique
26,27
 to address the 
imbalanced classes, train, and evaluate the classifiers. The negative diabetic instances 
were undersampled randomly to create a subset of the population that was negative for 
the diabetes outcome of interest. 
In addition to classifying an individual's diabetes at the time of data collection, we 
also trained and evaluated classifiers for predicting an individual's future risk to develop 
diabetes. This was done by using the status of the features at a point in time in the past to 
predict the presence or absence of diabetes in the future. For subjects that developed 
diabetes, we evaluated and used their age, status of comobidities, and their family health 
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history of diabetes at 5 years and 10 years before the year their diabetes was diagnosed. 
The 5- and 10-year gaps were arbitrarily chosen, considering that this dissertation mainly 
seeks to predict the future development of diabetes for public health prevention purposes. 
For subjects who did not develop diabetes by the time of data collection, we evaluated 
and used their age, status of comorbidities, and their family health history of diabetes at 5 
years and 10 years before the year of data collection. Furthermore, to test how well FHH 
by itself can predict the presence or future development of diabetes, we also trained and 
evaluated the classifiers with only features related to family health history and the 
subject's age and sex. 
This research was determined to be exempt from human subject research by the 








The target population for this analysis was the students’ parents, aunts, and 
uncles, which are shown in the highlighted area and include a total of 578,062 records 
(Figure 6.1). After data cleaning and preparation for machine learning, a total of 564,485 
(97.7%) records remained. These 564,485 records were used to train and evaluate the  





The results of the univariate analysis (Table 6.4) showed that the distribution of 
almost all features were significantly different (Odds Ratio 95% CI did not include 1.0) 
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between the diabetic and nondiabetic groups. The proportion of males and prevalence of 
smoking were not significantly different between the diabetic and nondiabetic groups. 
Drinking and exercise reported by the subjects showed a protective effect on the presence 
of diabetes (Odds ratio CI <1), while the remaining features were associated with an 
increased risk of diabetes (Odds Ratio > 1.0). The prevalence of diabetes increased  





The performance of the models based on the three classifiers is presented in Table 
6.5. All F-measures, as the weighted scores of both recall and precision, were greater than 
0.50 (F-measure value by random guesses). The F-measures across the three models 
ranged from 0.64 to 0.70 when using all features (including the subject’s sex and age 
group, comorbidities, lifestyle risk factors, and family health history) to predict the 
presence of diabetes. The F-measures ranged from 0.63 to 0.65 when using only the 
subject’s age and sex and family health history to predict the presence of diabetes. For all 
three models, the F-measure decreased when removing comorbidities and lifestyle risk 
factor features. The F-measure was lower when using the model to predict future onset of  





This study trained and evaluated classifiers to predict the future development of 
diabetes using a limited set of features that would be relatively easy to collect. These 
features included demographic characteristics (sex, age), family health history 
information about first-degree relatives (mother's diabetic history, father's diabetic 
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history, siblings' diabetic history, number and ratio of first-degree diabetic relatives), and 
optionally, other disease information and lifestyle risk factors.  
Characteristics of the Health Family Tree dataset provides advantages and 
disadvantages for this analysis. The Health Family Tree database used in this study has a 
large number of instances, and relatively small number of features. Further feature 
selection is often used to select the most relevant features when there are many features 
but not many instances. When there are hundreds to thousands of features, a model 
trained on all the features will have high variance and tends to be overfitted to the 
training data.
23
 When overfitting happens, the predictive model is too closely tied to the 
particular training data and will not apply well to fresh data. Feature selection is often 
needed to reduce the number of features to avoid the overfitting situation. The limited 
number of features in the HFT database gave us the advantage of analyzing the data 
without expending extra effort on feature selection. On the other hand, we were required 
to use an undersampling technique to address the imbalance created by the relatively rare 
presence of positive outcomes (diabetes) in the original dataset. The performance of all 
classifiers was improved after applying the undersampling technique. This improvement 
agreed with what other studies have used and found.
26,27
  
The diabetes prediction models built by the machine learning methods have 
several strengths. First, instead of assuming a statistical model and a hypothesis based on 
the model, the machine learning method's approach is to build a classifier based on a 
subset of the actual data and then validate the classifier with the remaining data. The 
properties of the data were considered and included in the building process from the 
beginning. Second, the Health Family Tree database has a large number of instances and 
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a relatively small number of features. This characteristic avoids a potential problem often 
seen in machine learning applied to datasets with many features:  the model overfits the 
data and is not generalizable.
28
 Third, a model built by machine learning may be easier to 
implement than statistical models. To apply the statistical prediction models to the data 
collected by other systems, there is a need for a reference population to calculate the 
expected disease incidence rates because the model predicts risk based on a comparison 
of the observed and the expected events of disease. Aside from the practical issues that a 
reference population is not always available and disease incidence rates of reference 
population are usually not available, the choice of reference population will have a direct 
effect on the results of the prediction. The prediction models can be applied to public 
health or population-based research for prevention purposes. To apply the machine 
learning models using data collected by other systems (such as the electronic health 
records or personal health records), public health professionals or population health 
researchers would need to create an input data set including at least sex, age, and family 
health history for first degree relatives. The input data set can then be applied to the 
prediction models to obtain classification of the individual's diabetes status. While 
predicting the presence of diabetes is not useful when that information may already be 
available in the clinical record or from interviewing a person,  the value of the 
classification is to predict the individuals that are currently nondiabetic but are likely to 
develop diabetes in the future (5 or 10 years). This population will be the target for public 
health education and interventions or risk stratification for population-based research.  
There are limitations in this study. The prediction was built on the target instances 
that were included in the Health Family Tree database collected from the Utah population 
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from 1983 to 2002. Race information was not included in the Health Family Tree 
database, but it would be expected that most of the study population was Caucasian 
because the Utah population is 89% Caucasian based on 2000 census data.
29
 The 
prevalence of diabetes differ among race/ethnicity groups after adjusting for age. From 
2007 to 2009, the prevalence of people aged 20 years or older diagnosed with diabetes 
was 7.1% for non-Hispanic whites, 8.4% for Asian American, 12.6% for non-Hispanic 
blacks, and 11.8% for Hispanics.
30
 Thus, the prediction may not predict diabetes for other 
populations representing different race groups. Similarly, the training and validation 
dataset used in this study did not include all known risk factors of diabetes such as body 
mass index and cholesterol level. Therefore, the model may be improved when adding 
these additional risk factors. Another limitation is the limited age range of the subjects. 
The target population used to train the classifiers were the high school students’ parents, 
aunts, and uncles, who are mostly distributed in the middle-aged groups. The classifiers 
may perform differently in the younger and older age groups. Finally, the diabetes 
documented in the Health Family Tree was not specified as type 1 or type 2 diabetes. 
Diabetes was defined as answering "yes" to the question, "Has he/she ever been told by a 
doctor that he/she suffers from diabetes?," and then the age of diabetes diagnosis was 
recorded for those with diabetes. Since type 2 diabetes accounts for 90-95% of total 
diabetes cases
31
 and most of the study target subjects (student's parents, aunts and uncles) 
were adults, the diabetes subtype reported in the target was more likely to be type 2 
diabetes. The predictive ability may not be true for predicting the more rare events of 
type 1 diabetes.  
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Despite these limitations, we developed models that can accurately predict the 
presence or future development of diabetes in 5 or 10 years. The models were based on a 
limited set of self- and proxy-reported information and can be used to identify high and 
low risk persons within Caucasian, middle-aged adult populations for population-based 






























Figure 6.1. Family unit structure and number of records in the Health Family Tree. 















Maternal aunts & uncles 
229,693 (22.48%) 















Table 6.1. Features that were included in the machine learning 
Features/Attributes Data type Values 
Demographic   
 Sex  Nominal Male, female 
 Age group Ordinal <20, 20-29, 30-39, 40-
49, 50-59, 60-69, ≥70 
Comorbidity   
Myocardial Infarction Nominal Yes, no 
Coronary heart disease Nominal Yes, no 
Stroke Nominal Yes, no 
Hypertension Nominal Yes, no 
High blood cholesterol Nominal Yes, no 
Breast cancer Nominal Yes, no 
Lung cancer Nominal Yes, no 
Colon cancer Nominal Yes, no 
First-degree relatives' diabetes history 
Diabetic mother Nominal Yes, no 
Diabetic father Nominal Yes, no 
Diabetic sibling(s) Nominal Yes, no 
Number of diabetic relatives Numeric 0-9 
Ratio of diabetic relatives Numeric 0-1 
Lifestyle  risk factors   
Smoking Nominal Yes, no 
Drinking Nominal Yes, no 
Overweight Nominal Yes, no 





Table 6.2. The advantages and disadvantages of the three chosen classifiers 
 Logistic regression Bayesian network Support vector 
machine 
Advantages Based on the 
traditional statistic 
method, robust for 
categorical outcomes 
Simple Good for both linearly 
and nonlinearly 
separable data: Find 
optimal hyper plane 
for linear separable 
data; Fin kernels for 
data that are not 
linearly separable  
 Features can be 
correlated because 
there are multiple 
ways to regularize 
Fast Nice theoretical 
guarantees regarding 
overfitting: 
Disadvantages Specified model ahead 
of time 
Harder to handle 
continuous features 
Slow 





Table 6.3. Confusion table of a two-class problem 
  True classes 
  Diabetes Non-diabetes 
Prediction by 
the algorithm 
Diabetes True positive (TP) False positive (FP) 




Table 6.4. Relationship between diabetes and individual features reported by 















Sex    Smoking   
Male 2.5 1.0(0.9,1.0) Yes 2.3 0.9(0.9,1.0) 
Female 2.6 1.0 (ref) No 2.5 1.0 (ref) 
Age   Drinking   
<20 0.8 1.0(ref) Yes 2.0 0.7(0.7,0.8) 
20-29 1.3 1.6(1.3,2.0) No 2.7 1.0 (ref) 
30-39 1.6 2.0(1.6,2.4) Overweight   
40-49 2.3 2.9(2.4,3.6) Yes 3.5 2.1(2.0,2.1) 
50-59 4.2 5.5(4.5,6.8) No 1.7 1.0 (ref) 
60-69 7.3 9.7(7.9,12.0) Exercise   
>70 8.3 11.3(8.9,14.3) Yes 1.8 0.6(0.6,0.7) 
Myocardial Infarction No 2.8 1.0 (ref) 
Yes 6.7 2.9(2.6,3.1) Diabetic mother 
No 2.4 1.0 (ref) Yes 4.9 2.2(2.2,2.3) 
Coronary heart disease No 2.2 1.0 (ref) 
Yes 6.4 2.7(2.5,3.0) Diabetic father 
No 2.4 1.0 (ref) Yes 4.4 1.9(1.8,2.0) 
Stroke   No 2.3 1.0 (ref) 
Yes 8.5 3.7(3.2,4.2) Diabetic sibling(s) 
No 2.5 1.0 (ref) Yes 11.1 6.8(6.6,7.1) 
High blood pressure No 1.8  
Yes 7.8 4.1(4.0,4.3) Number of diabetic first degree relatives 
No 2.0 1.0 (ref) 0 1.4 1.0(ref) 
High blood cholesterol 1 4.3 3.1(2.0,3.2) 
Yes 7.2 3.4(3.3,3.6) 2 9.0 6.8(6.5,7.2) 
No 2.2 1.0 (ref) 3 16.5 13.6(12.6,14.7) 
Breast cancer 4 23.3 20.8(18.5,23.5) 
Yes 4.6 1.9(1.6,2.2) 5 33.4 34.4(28.4,41.8) 
No 2.5 1.0 (ref) 6 44.1 54.2(40.3,72.9) 
Lung cancer 7 66.7 137(86,218) 
Yes 8.2 3.5(2.8,4.3) 8 44.1 54.2(27.5,106) 
No 2.5 1.0 (ref) 9 37.5 41.2(18.0,94.1) 
Colon cancer    
Yes 7.8 3.3(2.8,4.0)    
















Table 6.5. Evaluation of the three classifiers trained on the Health Family Tree data 
to predict diabetes (yes or no) at current time, in 5 years, and in 10 years 
 Recall Precision F-measure 












Using all features* 
BN 0.63 0.55 0.58 0.73 0.72 0.73 0.68 0.63 0.65 
LR 0.65 0.61 0.63 0.76 0.72 0.73 0.70 0.66 0.67 
SVM 0.61 0.56 0.59 0.77 0.75 0.75 0.68 0.64 0.66 
Using only age, sex and family health history 
BN 0.56 0.49 0.52 0.71 0.73 0.73 0.63 0.58 0.61 
LR 0.59 0.58 0.58 0.73 0.71 0.72 0.65 0.64 0.65 
SVM 0.58 0.55 0.58 0.74 0.73 0.73 0.65 0.63 0.64 
BN= Bayesian network 
LR= Logistic regression 
SVM=Support vector machine 
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Family health history (FHH) is an established disease risk assessment tool to 
stratify a healthy population and find individuals targeted for screening or health 
education for public health interventions or population-based research. Multiple 
advantages may exist when applying FHH for risk stratification and disease prevention.  
First, making good usage of FHH may reduce cost. One of the biggest problems related 
to healthcare in the United States is the cost. Since 1960, the US national health 
expenditure has been increasing rapidly.
1
 The expenditure was $2.7 trillion in the year of 
2011, which was 17.9% of the Gross Domestic Product.
1
 Besides technology, insurance, 
administrative cost, changes in health care prices, and medical malpractice, the 
prevalence of chronic diseases was one of the important reasons that have lead to the high 
cost.
2
 FHH may be used as a low cost, noninvasive screening tool for identifying 
populations at high risk for chronic diseases and implementing cost-effective primary and 
secondary prevention strategies. Another cost reducing benefit is through reducing time 
for the data collection. With the help of computerized and/or internet-based FHH tools, 
public health professionals and researchers could spend less or even no time to collect 
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FHH. Second, along with other information including genetic variations, biomarkers, 
environmental, and lifestyle factors, FHH can be included to develop comprehensive 
risk-prediction models used for genomic risk-stratified screenings.
3
 Meanwhile, the 
quality in terms of both the completeness and the accuracy of the information may be 
improved through well-designed and carefully-controlled systems. Furthermore, with the 
integration of FHH into electronic health records (EHR) systems, the collected 
information could be structured and reused for public health programs and population-
based research. The research performed for this dissertation addresses many questions 
that arise when suggesting the use of tools based on self-reported data and comparisons 
with population rates.  For example, we addressed the following questions:  
 What is the Accuracy of self- or proxy-reported Family Health History Data? 
Most current FHH data are patient self- and proxy-reported. This dissertation 
examined the accuracy of a database that contains more than one million self- 
and proxy-reported family medical history and lifestyle risk factor information. 
When compared to the Utah Cancer Registry and standardized public health 
survey data, the disease and lifestyle risk factor rates had similar patterns as 
compared to the rates from the public sources: all disease rates increased with 
age, smoking rates are higher in the middle age groups, and exercise rates 
decrease with age. Cochran-Mantel-Haenszel test results indicated that rates 
reported for stroke (overall, self- and proxy-reported), self-reported breast 
cancer, and self-reported lung cancer were not significantly different from the 
rates in the public data source, while the rates for other diseases and risk 
factors were significantly different. Chi-square tests by sex- and age- 
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subgroups indicated that most subgroup disease rates and smoking rates were 
underreported with a few exceptions in the extreme age groups; exercise rates 
were overreported compared to the rates in public data sources. The 
comparison between self- and proxy-reported data indicated that when 
reporting diseases, self-reported rates were closer to the rates in public data 
sources than proxy-reported, though both were underreported for most 
diseases; when reporting life style risk factors, self-reported rates were further 
away from the rates in public data sources, for both underreported smoking 
rates and overreported exercise rates.  
 Can the Health Family Tree Algorithm predict risk? Using a retrospective 
cohort design, we validated the predictability of the Health Family Tree 
algorithm using both the Tree database itself and the public data sources as 
reference to generate the expected incidence. Both validations indicated similar 
results that the very high risk scores (FHS ≥2) derived from the algorithm 
predicted the future risk for all included diseases, with or without considering 
lifestyle risk factors.  
 Can Family Health History be used to predict risks without the use of 
population disease rates? One factor that prevents the broader application of 
the traditional risk predictive model such as the Health Family Tree is its 
nonstraightforward implementation. To implement the algorithm to predict 
disease risk within other systems that collect family history information, 
reference population disease rates are required to calculate the expected disease 
events. This reference is not always available or straightforward to obtain. We 
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showed that machine learning methods can be used to train and evaluate 








For longitudinal, population-based research and public health screening, this 
research provided valuable indications about the effective use of FHH from data 
collection to the implementation of risk prediction models. For FHH data collection, we 
proposed 50 requirements including data, functional, and nonfunctional requirements to 
be considered. For risk prediction models, we validated a traditional statistical model and 
demonstrated how this model can be implemented in any system that collects FHH 
information. For longitudinal, population-based studies that contain a large amount of 
subjects' FHH information, the statistical risk prediction can be implemented similarly as 
the Health Family Tree, using the study population as a reference to generate the 
expected incidence. For other studies that do not have a large amount of subjects' FHH, 
or for a clinical system where the incidence of disease in the patient population does not 
reflect rates in the general population, the incidence from public data sources with 
interpolation can be applied to the risk prediction. The accuracy study of self- and proxy-
reported FHH provided indications that most concerned diseases were underreported 
statistically, so the risk predictions may be overestimated. This effect was confirmed by 
the comparison of risks derived from using Health Family Tree as a reference vs. using 
public data sources as a reference. Finally, the new risk predictive models built by 
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machine learning methods provided effective prediction for a specific subpopulation 




Contributions to Biomedical Informatics 
 
Biomedical Informatics is a multidisciplinary science that includes a wide range 
of subfields. This dissertation addressed challenges related to two major domains of 
Biomedical Informatics: acquisition of quality data and implementation of decision 
support using predictive methods to identify populations at risk. First, the research 
examined health information acquisition, including requirements for data and functions 
that needed to be included, and the examination of the quality of the family health history 
data that were self- or proxy-reported. Second, the research evaluated an existing tool for 
predicting risk and developed new algorithms using different methods that may be easier 
to implement in current EHRs. Specifically, we validated an existing risk prediction 
algorithm based on classic statistical models and built a new predictive model based on 
machine learning for easier implementation. Finally, this research is unique in its focus 
on population health rather than individual clinical decision support in that we evaluated 
the use of a tool that has the potential to support public health strategies that allow  





To further improve the use of FHH, there are research questions that need to be 
explored based on the work of this dissertation. To increase the interoperability of sharing 
FHH information (including the individual's medical information and family relationship) 
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between different systems and organizations, information modeling will be needed to 
structure how the information is organized for storage and transmissions. The Health 
Level 7 (HL7) community has been developing a clinical Genomics pedigree model.
4
 
This model is approved by the American National Standards Institute and is in the 
process of being accepted as an international standard. To improve the completeness and 
accuracy of FHH data, social networking may be used for data collection. With the 
advancement of the Internet and consumer technologies, more and more patients are 
involved in the decision process with their health and health care. Health2.0/medicine 2.0 
is an analogy to Web 2.0 technology and it is developing quickly.
5
 Multiple social 
networks/online communities such as Patient Like Me
6
 have been created for patients to 
exchange information and interact with each other. Compared to the traditional method of 
collecting FHH through one member of the family, social networks allow multiple family 
members to participate, which may increase data quality and completeness but may 
introduce new problems such as how to resolve conflicting information. To further 
explore the application of supervised machine learning methods to the Health Family 
Tree data, predictive models of other diseases that were collected by the database should 
be built and evaluated. To streamline the process of using FHH for disease risk 
assessment, future work is needed to integrate FHH prediction models into the EHR or 
personal health records (PHR). Implementers need to consider the differences in the 
implementation requirements and the output provided to the user when choosing a risk 
predictive model. For example, a statistical risk model requires expected disease 
incidence rates from a reference population or data source and uses the relative risk of the 
individual to predict risk. In contrast, a machine learning model requires a validated 
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model and access to the data fields required by the model and can then output a disease 
classification prediction based on defined levels of recall and precision. Another future 
direction concerns how to communicate risk assessment results to the public and direct 
them to an accurate perception of their risks. According to the multiple theories such as 
the Health Belief Model,
7
 Stages of Change Model,
8
 and the Theory of Planned 
Behavior,
9
 perceived risk and attitude are two of many important factors that lead to 
behavior change. Past studies have shown that an individual’s attitude and perception of 
risk is affected by the manner in which information is presented to the user.
10
 Also, 
patients may have different preferences between absolute risk and relative risk.
11
 Thus, 
how to accurately deliver the risk assessment information to the public is another  





In conclusion, to better use family health history to predict an individual’s or 
population's risk of developing selected chronic diseases, especially in the context of 
public health or population-based research, various requirements for family health history 
tools proposed herein should be considered when choosing an existing tool or building a 
new tool; risk prediction models may be built through various ways including statistics 
and machine learning; self- or proxy-reported family health history data collected by 
research projects such as Health Family Tree may generate lower disease prevalence or 
incidence rates compared to the rates generated from data collected by public health 
surveys or cancer registries. Disease predictive models built by the Health Family Tree 
program using the self- and proxy-reported data are still valid for predicting the future 
development of  multiple chronic diseases for an unaffected adult between 20 and 99 
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years of age. These findings may be especially useful when developing strategies to 
screen populations for common chronic diseases and identifying those at highest risk for 
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